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Weil die Frage Warum immer einen zureichenden Grund will
und die Verbindung der Erkenntnisse nach dem Satz vom
zureichenden Grunde die Wissenschaft vom bloßen Aggregat
von Erkenntnissen unterscheidet, ist gesagt worden, dass das
Warum die Mutter der Wissenschaften sei. Auch findet sich,
dass in jeder derselben Eine der Gestaltungen unsers Satzes,
vor den übrigen, der Leitfaden ist; obgleich in derselben auch
die andern, nur mehr untergeordnet, Anwendung finden. So
ist in der reinen Mathematik der Seinsgrund Hauptleitfaden
(obgleich die Darstellung in den Beweisen nur am Erkennt-
nisgrunde fortschreitet); in der angewandten tritt zugleich das
Gesetz der Kausalität auf; und dieses gewinnt ganz die Ober-
herrschaft in der Physik, Chemie, Geologie u.a.m. Der Satz
vom Grunde des Erkennens findet durchaus in allen Wis-
senschaften starke Anwendung, da in allen das Besondere
aus dem Allgemeinen erkannt wird. Hauptleitfaden und fast
allein herrschend aber ist er in der Botanik, Zoologie, Min-
eralogie und andern klassifizierenden Wissenschaften. Das
Gesetz der Motivation ist, wenn man alle Motive und Maxi-
men, welche sie auch seien, als Gegebenes betrachtet, aus dem
man das Handeln erklärt, Hauptleitfaden der Geschichte,
Politik, pragmatischen Psychologie u. a. — wenn man aber
die Motive und Maximen selbst, ihrem Wert und Ursprung
nach, zum Gegenstand der Untersuchung macht, Leitfaden
der Ethik.
—Arthur Schopenhauer
Für meine Mutter Anja und meinen Sohn Paul Levi
Zusammenfassung
Neuroinflammation beschreibt Entzündungsprozesse im zentralen Nervensystem.
Die Ursachen für Neuroinflammation sind vielfältig: von Infektionen über Schädel-
Hirn-Traumata, Toxine und Autoimmunreaktionen. Während im restlichen Kör-
per aktivierte Makrophagen und dendritische Zellen die erste Verteidigungsebene,
die angeborene Immunantwort, darstellen, produzieren im Gehirn Astrozyten und
Mikroglia pro-inflammatorische Zytokine und induzieren damit Neuroinflammation.
In der Pathogenese unterschiedlicher neurodegenerativer Erkrankungen, beispiel-
sweise der Alzheimer-Erkrankung, ist Neuroinflammation und eine anhaltende Im-
munaktivierung als Risikofaktor identifiziert worden.
In dieser Arbeit habe ich überprüft, welche Effekte andauernde Neuroinflamma-
tion durch den Parasiten Toxoplasma gondii auf das Gehirn von unterschiedlichen
Mausstämmen hat. Außerdem habe ich in diesem Zuge überprüft, ob diese Ef-
fekte über den p75 Neurotrophinrezeptor vermittelt werden. Neurotrophine sind
Signalstoffe, die weitreichende Wirkungen auf Neurone haben. Sie vermitteln die
Aufrechterhaltung und den Abbau bestehender neuronaler Verbindungen, die Dif-
ferenzierung von Nervenzellen. Da sie außerdem von Mikroglia und anderen Zell-
typen des Immunsystems produziert werden, stellen sie eine direkte Verbindungen
zwischen dem zentralen Nervensystem und dem Immunsystem dar.
Die Daten zeigen, dass der C57BL/6 (B6) Mausstamm empfindlicher auf den
Parasiten reagiert als BALB/c Mäuse. Neben einem deutlichen Gewichtsverlust
in den infizierten B6 Tieren, zeigen sie außerdem deutlichere Veränderungen in
der Architektur der Neurone. Während beide Mausstämme mit einer starken Ak-
tivierung der Mikroglia auf Toxoplasma gondii reagieren, zeigt sich jedoch, dass die
Morphologie der Mikroglia stammspezifisch auf die Infektion reagiert und unter-
schiedliche Phenotypen aufweist.
Der zweite Teil der Daten zeigt, dass in B6 Mäuse, denen der p75 Neurotrophin-
rezeptor fehlt (knock out), die Neuronenarchitektur weniger stark durch die Infek-
tion verändert werden, als das im Wildtyp der Fall ist.
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Abstract
Neuroinflammation subsumes inflammatory processes in the central nervous sys-
tem(CNS). The insults causing for neuroinflammation are diverse: infections, trau-
matic brain injury, toxins, and autoimmunity are among these. In the periphery
activated macrophages and dendritic cells represent the first line of defense - the
innate immunity. In the central nervous system pro-inflammatory cytokines are re-
leased by microglia, the brain resident macrophages, and astrocytes. This induces
neuroinflammation. For the progression of various neurodegenerative diseases, in-
cluding, e.g., Alzheimer’s Disease, neuroinflammation, and prolonged immune ac-
tivity have been identified as a risk factor.
In this thesis, I investigated which effects the chronic infection with the para-
site Toxoplasma gondii (T. gondii) and thereby prolonged neuroinflammation take
on the brains of different laboratory mouse strains. Additionally, I investigated
whether these effects are in part mediated by the p75 neurotrophin receptor. Neu-
rotrophins are secreted proteins that belong to a class of growth factors. They have
shown to be capable of regulating neuronal survival, differentiation, growth, and
maintenance among other. Intriguingly neurotrophins are also expressed and se-
creted by microglia and other cell populations of the immune systems and thereby
represent a direct signaling connection between the CNS and the immune system.
My data shows that the C57BL/6 (B6) mouse strain is more susceptible to the
parasite than BALB/c mice. Additionally to a significant weight loss upon infec-
tion B6 mice also show more drastic changes in neuronal morphology than BALB/c
mice. Both strains react strongly microglial activation to T. gondii infection. Inter-
estingly microglial morphology upon infection is strain specific and display different
phenotypes.
The second part of the data shows that B6 mice lacking the p75 neurotrophin
receptor (knock out) show a milder reaction to the T. gondii infection on their
neuronal architecture compared to the wild type.
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1 Introduction
1.1 Neuroinflammation
Neuroinflammation is commonly named as one major contributor to multiple neu-
rological diseases. An acute neuroinflammation is most often considered neuropro-
tective by default while a long lasting or even chronic neuroinflammation triggers
signal cascades causing neurodegeneration. This damaging effect has been subject
to studies in the context of neurodegenerative disorders like Huntington’s disease
(HD), amyotrophic lateral sclerosis (ALS) and Alzheimer’s disease (AD) among
others.
Any alteration in the CNS’ functional and cellular integrity induces neuroinflam-
mation. The process of neuroinflammation aims to reinstate the tissue homeostasis
by inducing different repair mechanisms (Goldszmid and Trincheri, 2012). How-
ever, if the precise regulation of this processes evades controlled conditions, the
initial inflammatory response can amplify exceedingly, and as a result, the protec-
tive effect transforms into a neurotoxic effect, causing collateral destruction and
resulting in a possibly severe progression of a pre-existing disease.
Neuroinflammation is a highly dynamic set of processes in which different cell
types participate (Microglia, section 1.1.2.1; Astrocytes, section 1.1.2.2; Neurons,
section 1.1.2.3), by proliferating, migrating, releasing immune active factors (e.g.
reactive oxygen species and cytokines, section 1.1.3), displaying surface proteins
(e.g. MHC-I/II) and participate in phagocytosis and antigen presentation as a
response to protein aggregates, glial products (e.g. cytokines) and neuronal degen-
eration.
Intriguingly cytokine signalling upon neuroinflammation actively mediates the
regulation of several CNS functions like neuroendocrine release, neurotransmis-
sion, synaptic plasticity, neural circuitry, behaviour, memory function and cogni-
tion (Camacho-Arroyo et al., 2009; del Rey et al., 2013; Aprile-Garcia et al., 2013;
Cuartas and Jorge 2014; Liu et al., 2017).
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Altered cognitive or behavioral capacities are therefore presumably a possible
consequence of misregulated cytokine signaling which in turn can result in pre-
viously mentioned neurodegenerative diseases or mental disorders (Lynch 2002;
Magaki et al., 2007; Holmes et al., 2009; McAfoose and Baune 2009, Brosseron et
al., 2014).
1.1.1 Neuroinflammatory makers
Neuroinflammation is not recognized on the same hall marks as inflammation in
general, as defined by Celsus (25 BC), being dolor, tumor, rubor, and calor. Instead,
neuroinflammation is recognized by the expression of cytological makers of innate
immune response, e.g., pro-inflammatory cytokines and chemokines. Additionally,
morphological changes of microglia and astrocytes are characteristics of neuroin-
flammatory processes. The infiltration of circulating leucocytes or macrophages as
part of the adaptive immune response are involved depending on the nature of the
pathological event (Eikelenboom et al., 2002; Amor et al., 2010). While the CNS
was previously thought to be an immune privileged organ, it is nowadays generally
accepted that adaptive immune response and innate immune responses occur in
the CNS and are coming into play to a varying extent during neuroinflammatory
processes.
1.1.2 Cell types playing a critical role
1.1.2.1 Microglia
In contrast to the periphery, the central nervous system does lack the standard
lymphatic systems. It contains a limited range of different immune cells and has,
therefore, in former times, been considered to be immune privileged in former times.
These days it is established that resident microglia, recruited macrophages and
dendritic cells (DCs) in the CNS can prompt an all over immune reaction to patho-
logical conditions; injury and disease.
Microglia were first recognized by Nissl in 1880 and later studied by Pío del
Río Hortega. The Spanish neuroanatomist described them as resting ramified cells
using silver carbonate staining methods (del Río Hortega 1932). Nowadays our
understanding of microglia has shifted completely from them being a ‘silent’ cell in
healthy brain to an actively involved component in cognition, behavioral functions,
CNS physiology, and neurogenesis.
2
1.1 Neuroinflammation
These microglial cells are now well accredited as elementary contributors in the
pathogenic progression of several neurological disorders and diseases (Heneka et al.,
2010; Parpura et al., 2012; Verkhratsky et al., 2014).
Microglia are the surveyors of the CNS, actively extending and retracting their
processes and by these means maintaining the post- and pre-synaptic elements and
fine tuning of neuronal circuitry. Thus, a disruption of this homeostatic functions
possibly contributes to the progression of neuronal disorders. Microglia are migra-
tory cells of the CNS that continuously survey their surroundings with their highly
motile processes for any kind pathogenic event (Gehrmann et al., 1995) and rep-
resent ~15–20% of the total glial population (Carson et al., 2006). Microglia are
referred to as the CNS’ resident macrophages and they are fully immunocompe-
tent phagocytic cells and constitute the innate immunity, the first line of defense,
against any CNS damage or insult and exhibit functional and structural plastic-
ity. They are considered responsible for maintenance and homeostasis within the
CNS and undergo substantial structural transformations to appropriately perform
several immunological functions. While under normal conditions, the microglia cell
bodies stay nearly stationary and the microglial processes scan the environment
(extracellular space, blood vessels) and directly communicate with neurons and
astrocytes. Uniquely microglia derive from yolk sac myeloid progenitors that are
distinct from those which yield monocytes or macrophages. These progenitors mi-
grate to the central nervous system before its vasculogenesis (Ginhoux et al., 2010).
In their resting state microglia is characterized by a small cell body with highly
ramified processes - and can thereby easily be distinguished morphologically from
dendritic cells and macrophages.
Activation of microglia upon and CNS insult or immune breaching has been
widely observed (Saxena et al., 2007; Patro et al., 2010a, 2013; Nagayach et al.,
2014a, b, 2015; Sharma et al., 2015). A rapid transformation of these activated
immune cells into a reactive phenotype is characterized by a highly ramified mor-
phology. Activated microglia repair damaged tissue by phagocytizing cell debris
and sustain healing processes (Hanisch and Kettenmann 2007; Kettenmann et al.,
2011). More and more evidence shows that microglia activation is also liable in
aggravating the neurodegeneration (Block and Hong 2005; Venero et al. 2011).
In their position as the carer for maintaining the general homeostasis of the
central nervous system, they are equally important in health and disease. Follow
sections will deal with their impact on neuronal maturation and learning as well as
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their response to neuroinflammation.
1.1.2.1.1 Microglia shaping neurons - synaptic pruning Microglia have been
studied mostly in the context of CNS disease, injury or similar pathological events
(Hanisch and Kettenmann, 2007). Prevailing research shows a much more versa-
tile array of functions for these cells. Besides their role in fighting off pathogens,
microglia prune synapses during CNS development by actively engulfing synaptic
material and phagocytizing excess structures (Paolicelli et al., 2011). Also, mi-
croglia participate in the regulation of synaptic plasticity and function. While
scanning their environment microglia make direct and transient connections with
dendritic spines, synapses, axons, and somata. Further evidence for a more sub-
stantial role of microglia in cognitive functions was provided by showing activity
depended neuron-microglia interaction (Tremblay et al., 2010, Schafer et al., 2012).
Removing microglia from the adult mouse brain results in learning impairment and
intriguingly genetically depleting the neurotrophin BDNF from microglia leads to
a similar phenotype as the complete ablation of microglia, strongly indicating that
microglial derived BDNF contributes to the synaptic remodeling associated with
memory and learning (Parkhurst et al., 2013).
The participating receptors and signaling pathways remain largely unknown.
1.1.2.2 Astrocytes
It is established for a very long time that upon damage, loss, and degeneration of
neuronal tissue, among other glia, astrocytes proliferate and fill the resulting gaps,
in some cases even leading to tissue scaring (astrogliosis). Their role in neuroin-
flammation has been the subject of study only recently. Similar to microglia CNS
damage activates astrocytes, which contribute to neuroinflammation by cytokine
and chemokine secretion (Miller 2005; Tandon 2007). Their inflammatory response
is not as prominent as one of microglia cells (Streit et al., 1999), although they get
activated by pathological challenge (Aloisi 1999). It has been shown that in neu-
rodegenerative disorders microglial response plays a bigger role than the astrocytic
response (Teismann et al., 2003; Vehmas et al., 2003).
1.1.2.3 Neurons
The idea that neurons play a solely passive role in neuroinflammation has been
thoroughly dismissed by findings indicating that neurons are actively contributing
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to regulatory immune responses in the brain. Neurons express factors like mem-
brane spanning proteins (CX3CLI; CD22; CD200; NCAM; ICAM) that regulate
neuroinflammatory signal cascades (Tian et al., 2009; Doll et al., 2014). Addi-
tionally, the expression of cyclooxinase2 (COX-2), which is induced by IL-1β, has
been found in early stages of Alzheimer’s disease (AD) (Hoozemans and O’Banion
2005).
1.1.2.4 Peripheral immune cells recruited into the CNS
Chronic CNS inflammation and subsequent activation of microglia triggers cells of
the adaptive immune system to invade the brain. Degenerative disorders usually are
characterized by local inflammation from the above mentioned CNS resident cells
and by the infiltration of peripheral leucocytes alike (McGeer et al., 1989). Indeed,
under healthy conditions T-cells are nearly non-present in the CNS while in patients
suffering from Parkinson’s Disease, multiple sclerosis or traumatic brain injuries
were observed to enter affected areas (Mantovani et al., 2009; Ankeny and Popovich
2009; Neumann et al., 2002). Especially in Alzheimer’s Disease, it has been shown
that patients have an atypical inflammatory response, mainly from macrophages
and microglia and additional recruitment of monocytes into the CNS (Perry et al.,
2007). A distinction between macrophage and microglia versus infiltrated CD8,
CD4 monocytes and T-cells has yet to be established (Lucin and Wyss-Conray
2009).
1.1.3 Pro-inflammatory markers
In direct consequence of a CNS insult, a variety of cytokines is expressed to cope
with the injury and to facilitate repair. The primary source are the activated
microglial cells, producing IL-1, TNFα, NO, PGE2 and more. These are mainly
involved in prolonged inflammation (Swardfager et al., 2010; Murray et al., 2015)
and have been studied to great extend in Parkinson’s Disease (Allan et al., 2010),
multiple sclerosis (Block and Hong 2005), Alzheimer’s Disease (Misiak et al., 2012;
Lue et al., 1996; Akiyama et al., 2000), amyotrophic lateral sclerosis (Henkel et al.,
2004) but also in general ageing processes (Lucin and Wyss-Conray 2009; Villeda
et al., 2011). Griffin et al. could show (1995) that in AD patients IL1β show a 6
fold increase compared to healthy control patients, emphasizing it playing a role
in chronic CNS diseases. Additionally, Swardfager et al. also showed (in 2010)
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that AD is accompanied with an elevated inflammatory response by showing an
increased concentration of IL-6, IL-12, IL-18, IL1β, and TNF in the periphery.
Pro-inflammatory cytokines initiate downstream cascades which details still need
to be defined.
1.2 Pyramidal cell - dendritic structure
The discrimination of individual neuronal morphology was first possible after the
development of the Golgi staining in the late nineteenth century. This silver staining
labels sparsely but intensely neuronal structures and allowed the neuroanatomist
Ramón y Cajal (1888) meticulously draw and describe for the first time the elabo-
rate dendritic aborization of diverse neuronal populations.
One major distinction proved to be that some neurons appear to have smooth
dendrites, while some have plenty dendritic protrusions (dendritic spines). Nearly
a century later it was shown that neuron with many spines are excitatory and glu-
tamatergic and smooth neurons mostly inhibitory and GABAergic. Sophisticated
electron microscopy experiments on Golgi-stained cells showed that each spine con-
tains a synapse characterized by presynaptic vesicles and a broad postsynaptic den-
sity (Gabbott and Somogyi 1986; Kubota 2014; Morishima et al., 2011; Thomson
and Deuchars 1997).
With the advancements in electron microscopy experiments were conducted on
Golgi-stained neurons, which showed that every synapse is characterized by round
presynaptic vesicles and a postsynaptic density (Hersch and White 1981; LeVay
1973; Parnavelas et al., 1977).
Pyramidal neurons are named after the shape of their cell soma. They are fur-
ther characterized by distinct basal and apical dendritic trees, and one single axon
usually emanates from the basal part of the soma making several excitatory glu-
tamatergic synaptic contacts along its length. (fig. 1.1). While pyramidal neurons
are by no means identical, they share distinct functional principles. Pyramidal
cells are found in various CNS regions, and they have been studied to great length,
especially in the hippocampal CA1 area and in the cortical layer V.
Synaptic input takes place at different domains in pyramidal neurons. The axon
and the soma receive inhibitory input by GABAergic (γ-aminobutyric acid) neu-
rons. Excitatory input arrives mainly through the dendrites from multiple sources.
Generally it has been observed that proximal dendrites receive their input from
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Figure 1.1: Pyramidal neuron of the hippocampus - Pyramidal cells depict a approxi-
mately triangular cell soma; the dendrites emerge from both the apex (the apical
dendrite) and the base (the basal tuft). Pyramidal cells are present in the hippocam-
pus and throughout the cerebral cortex. The dendrites are covered in dendritic spines
(Adapted from Kandel et al., 2012).
locally adjacent excitatory sources and the distal apical tuft from more distant
locations (Cauller and Connors, 1994; Larkum et al., 2004). The different mor-
phological properties of apical and basal dendrites suggest a distinct integration of
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their input (Spruston, 2008).
Hippocampal CA1 pyramidal neurons receive input from the entorhinal cortex
to the distal tuft trough the perforant pathway. The proximal dendrites receive
their excitatory input via the Schaffer collaterals from the hippocampal CA3 region
(Ishizuka et al., 1990; Li et al., 1994).
1.2.1 Dendritic spines
In his descriptions and drawings of neuronal structures, Ramón y Cajal also showed
dendritic spines for the first time. Since then technical advances have driven our
knowledge beyond the limits of classic light microscopy. Several neuron types
throughout the CNS form small membrane protrusions from the dendritic shaft
which then differentiate into various types of dendritic spines. Depending on the
CNS region and neuron type, different spine densities occur in all vertebrates. The
variance in size and shape of spines strongly indicates a high degree of functional
diversity (fig. 1.2).
Dendritic spines are commonly classified into three to four distinct types: mush-
room, thin, stubby and filopodia-like. Mushroom spines have a large head with
a substantial post-synaptic density. Thin spines have a thinner spine neck and a
small bulbous head. Stubby spines lack a visible neck and filopodia like spines are
long, hair-like and devoid of a head.
The changes in spine morphology are tightly linked to biochemical reactions
taking place within the spine. The spine head is isolated from the metabolism of the
dendrite by the spine neck. Compartmentalization also effects calcium dynamics,
revealing a link between function and morphology (Yuste et al., 2000).
1.3 Neurotrophins
Any secreted factor that has sustaining or nourishing effects on neurons can be
understood as neurotrophic factors. While many different molecules do have those
effects on neurons (e.g., neutrin, artemin and persephin) the family of neurotrophins
has been subjected to intense study for more than half a century. The most
archetypical neurotrophic factor, the neurotrophin "nerve growth factor" (NGF)
was already discovered in 1952, and its essential role in survival and neurite out-
growth was shown by Levi-Montalcini and Angeletti in 1963, work for which she
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Figure 1.2: Structure and organization of spines Schematics of the most common spine
morphologies based on an established classification system with four main categories.
On a single dendrite a continuum of these shapes can be found and the morphology
of a given spine can change rapidly (adapted from Rochefort and Konnerth, 2012).
was awarded the Nobel Prize in Physiology or Medicine in 1986 (together with
Stanley Cohen). The other members of the neurotrophin family (BDNF, NT-3,
and NT-4) were discovered in the 1980s and 1990s after PCR analysis. NGF and
BDNF belong to a genetically conserved family (Barde et al., 1982; Hohn et al.,
1990; Jones and Reichardt 1990; Maisonpierre et al., 1990; Rosenthal et al., 1990;
Berkemeier et al., 1991; Hallbook et al., 1991; Ip et al., 1992). All the neurotrophins
are short peptides and have an approximate molecular weight of 13 kDa and exist
as non-covalently linked homodimers. Neurotrophins mainly interact with two dif-
ferent cell surface receptor types (fig. 1.3); the members of Trk family of receptor
tyrosine kinases and the p75 neurotrophin receptor (p75NTR).
This research emphasis has since then shifted a little away from pursuing a role
for neurotrophins in neuroprotection, nevertheless the last 15 years has generated
formidable progress in elucidating the functional roles of the neurotrophins and
their receptors in normal development and adult physiology, their mechanisms,
and also their role in the pathophysiology in a state of disease.
The last decade has widely expanded the knowledge on neurotrophins and their
receptors, following the discovery that the neurotrophin pro-peptides have dis-
tinct neuronal effects mediated by novel receptor constellations (homo- and het-
erodimers), including sortilin, Nogo-A, and the low-affinity neurotrophin receptor
p75NTR.
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Figure 1.3: Neurotrophins bind to the Trk receptors and p75NTR - Each neurotrophin
binds to its cognate Trk receptor. The p75NTR can bind all the neurotrophins with
low affinity, and the proneurotrophins with high affinity.
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1.3.1 Receptor Activation by Mature Versus
Pro-neurotrophin
Figure 1.4: Pro-neurotrophins bind
p75NTR with high affinity- Pro-neurotrophins
possess a high binding affinity to a receptor com-
plex composed of p75NTR and sortilin, inducing
apoptosis. Cleaved, mature neurotrophins in
contrast prefer binding a complex composed of a
p75NTR with a Trk receptor to mediate survival
and differentiation. Adapted from Siegel et al.,
2011
Neurotrophins are generated by trans-
lating from their mRNA as pro–
neurotrophins which are post-trans-
lationally processed by proteolytically
cleaving them. The pro forms of the
neurotrophins were initially categorized
as inactive precursor proteins in con-
trast to the processed peptides. Nu-
merous studies afterward showed that
the pro-neurotrophins are ligands for
p75NTR, recognizing them as physio-
logically active. Nowadays it is well
understood that neurotrophin signaling
depends on the balance between pro-
neurotrophins vs. mature as well as
the configuration of the target recep-
tor complex. The affinity of pro versus
mature neurotrophins depends mainly
on the interactions of p75NTR and its
present co-receptor (Chao et al., 2003).
Cell growth, differentiation, and sur-
vival is enhanced by mature neu-
rotrophin signaling via Trk receptors
which is in turn increased by heterodimerization with p75NTR (Chao 1994; Es-
posito et al., 2001; Hempstead 2006). In opposition, p75NTR pairing with sortilin
increases the binding affinity to pro-neurotrophins, resulting in apoptosis inducing
cell signaling (fig. 1.4). ProNGF and proBDNF have both been demonstrated to
activate a p75NTR -dependent apoptotic cascade (Beattie et al., 2002; Harrington et
al., 2004; Teng et al., 2005; Lebrun-Julien et al., 2010; Nykjaer and Willnow 2012).
As NGF has been the primary focus at the beginning of neurotrophin research, its
pro-form has analogously been best studied, compared to the other pro-neurotrophins.
Different groups demonstrated proNGF as being released by various cell types
11
1 Introduction
Hasan et al., 2003; Bruno and Cuello 2006; Domeniconi et al., 2007; Yang et al.,
2009a, b). It was also shown that ProNGF gets cleaved intracellularly as well as
extracellularly by different types of enzymes (Lee et al., 2001). This indicates yet
another potential for cell-cell interactions mediated by the neurotrophin system.
Loss-of-function experiments confirmed the role of the different pro-neurotrophins
(proBDNF, proNGF) by blocking the binding by specific antibodies(Harrington et
al., 2004; Volosin et al., 2008; Fan et al., 2008). P75NTR knockout mice (Exon3 -/-)
suffer less from seizures (Volosin et al., 2008), ligation by proNGF (Beattie et al.,
2002) or after axotomy (Ferri et al., 1998; Syroid et al., 2000). Comparable effects
are observed in sortilin knockout mice (Jansen et al., 2007).
The ambivalence between the consequences of mature neurotrophin and pro-
neurotrophin signaling has raised the conjecture that a dysregulation could facilitate
the progression of many neurodegenerative diseases. Further evidence arouse from,
e. g., Fahnstock et al. (2001), who showed that proNGF is increased two-fold in the
parietal cortex of individuals with Alzheimer’s disease (AD).
1.3.2 The p75 neurotrophin receptor
The first receptor identified for NGF was the p75NTR (Chao et al., 1986; Radeke
et al., 1987), and was initially named after being a low-affinity receptor for NGF
(low-affinity NGFR). The high-affinity NGFR, TrkA, was identified half a decade
later (Hempstead et al., 1991; Kaplan et al., 1991; Klein et al., 1991). The receptors
were renamed as more members of the Trk receptor family were identified.
The functionality of p75NTR remained elusive and was questioned for many years,
because of the absence of kinase activity. In order to understand the bandwidth
of effects downstream of p75NTR, it has to be understood that there are various
interactions with co-receptors. The p75NTR is a single membrane spanning protein
from the tumor necrosis factor (TNF) receptor family, containing four cysteine rich
areas within the extracellular region that are consequential for neurotrophin binding
affinity and receptor-receptor interactions. The p75NTR forms both homodimers and
heterodimers. The specific receptor interactions provide a wide range of signaling
pathways, allowing a few receptors to fulfill many different responses. The p75NTR
partners with three different types of co-receptors: the Trk receptors (A, B and C),
sortilin or Nogo receptors (fig. 1.5).
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1.3.2.0.1 p75NTR interactions with the Trk receptors An important difference
between other death receptors and the p75NTR is the inability to auto-activate the
apoptotic pathway, additionally to its above-mentioned lack of a kinase domain.
Therefore p75NTR exerts its functions by interacting with other receptors. Het-
erodimers consisting of Trk receptors and p75NTR promote growth and pro-survival
signaling while increasing the affinity of major neurotrophins to the respective Trk
receptor 100-fold compared to the Trk homodimer (Hempstead 1991; Bibel 1999).
This is especially important during development when the increased efficacy of
TrkA–p75NTR signaling initiates NGF dependent neuronal survival and growth.
Downstream pathways of Trk activation typically includes the PI3K-Akt, extracel-
lular regulated kinases (Erk) and phospholipase C–γ (PLC γ). Bui et al. could
demonstrate in 2002 that in the absence of p75NTR (ExonIII Knockout; Lee et al.,
1992), the ability to activate Akt signaling on PC12 cells via TrkA is decreased.
The fact p75NTR interacts with TrkA, B and C stresses the ability for p75NTR to
control a wide range of aspects of neurotrophin signaling.
1.3.2.0.2 p75NTR interactions with truncated Trk receptors TrkA, B and C
have variants that are derived from alternate splicing, which lack the kinase do-
main. The truncated TrkB is best characterized for being expressed in the mature
CNS and has been suggested to modulate full-length TrkB signaling. Formation of
dendritic spines (Michaelsen et al., 2010) and filopodia (Hartmann et al., 2004) is
controlled by these splice variants working in concert with p75NTR. Long-term po-
tentiation (LTP) and long-term depression (LTD) are both impaired in truncated
TrkB over-expressing transgenic mice. This suggests that truncated TrkB together
with p75NTR promotes the opposite effect as the full-length TrkB, limiting its ac-
tions.
Transactivation of Trk Receptors Another level to regulate neurotrophin receptor
signaling remains still mainly elusive: the potential for Trk receptors to signal
through transactivation. Studies showed (Lee et al., 2001, 2002; Poo, 2001) that
other receptors catalyze the phosphorylation of Trk receptors. Puehringer et al.
(2013) could show that in the absence of BNDF and NT-3 epidermal growth factor
(EGF) binding to its receptor (EGFR) and promotes the activation of TrkB and
TrkC to regulate the migration of newborn cortical neurons. In other cases, trans-
activation promotes cell survival by increasing Akt activity (Chao et al., 2006).
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Known events are connected to interactions with G-protein protein coupled recep-
tors (Filardo, 2002), as observed with adenosine receptors.
1.3.2.0.3 p75NTR interactions with sortilin Aside the Trk receptors sortilin has
been the most intensely studied co-receptor of p75NTR. Sortilin itself is a protein
with many different functions and interaction partners (Nykjaer and Willnow 2012).
Two discoveries put a greater focus on its interaction with p75NTR though: a)
p75NTR- sortilin heterodimers downstream activate apoptotic pathways, a process
generally used during development of the CNS (Hempstead 2006; Kraemer et al.,
2014a, b) especially pro-neurotrophins bind the p75NTR-sortilin heterodimer with
high affinity, initiating the cell death signal (Lee et al., 2001), by the JNK-3–c-Jun
pathway. Different neuronal sub-populations are partly driven to initiate apoptosis
during development by means of p75NTR, e. g. in sympathic neurons, retinal neurons
and oligodendrocytes (Frade and Barde, 1998; Huang and Reichardt, 2001; Beattie
et al., 2002; Teng, 2005; Jansen et al., 2007; Kenchappa et al., 2010; Nykjaer and
Willnow, 2012; Roberti et al., 2014). Cell death is by no means the only known
function of sortilin, although intensely studied, it has also been described principally
as an intracellular sorting protein. Vaegter et al. demonstrated in 2011 that sortilin
controls pro-BDNF secretion by assisting in intracellular, anterograde trafficking.
This underlines its importance for neuronal function and survival.
1.3.2.0.4 p75NTR interactions with Nogo Another mechanism to control neu-
ronal growth is provided by interactions of Nogo-receptor 1 (NgR1) with p75NTR.
Axonal growth is suppressed by signaling via NgR1 interacting with the p75NTR in
a receptor complex which is bound by MOG, MAG or Nogo. This ligand-receptor
conglomerate mediates the dissociation of Rho-GDI from RhoA (Yamashita et al.,
1999), triggering growth cone collapse by interaction with LINGO-1 (Mi et al.,
2004.). Coincidentally, Rac gets inhibited, which does limit the stimulus to initiate
the growth cone formation (Deinhardt et al., 2011). This is important in devel-
opment and after injuries, when the CNS needs to recover and repair the former
structures. Therefore these processes have been studied and focused on to target
neuronal growth restoration therapeutically (McDonald et al.. 2011).
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Figure 1.5: Neurotrophin receptor dimerization and signaling - The Trk (tyrosine re-
ceptor kinase) receptors can form homodimers and heterodimers with the p75NTR.
The p75NTR is a membrane-spanning neurotrophin receptor belonging to the tumor
necrosis factor receptor superfamily (TNF) that binds all the four neurotrophins:
BDNF, NGF, NT–3 or NT–4, the mature isoforms with low affinity and the pro-
neurotrophins with high affinity. The intracellular domain (ICD) of the p75NTR
contains a death domain that, because of the p75NTR’s lack of kinase activty, is
not able to activate itself and therefor requires interactions with other receptors or
effector proteins. The p75NTR interacts with three different receptor classes: Nogo
receptor, the Trk receptors and sortilin. Heterodimers with one of the Trk receptors
leads to a higher affinity to mature neurotrophins and mediates surival and growth
signaling PI3K-Akt, ERK or PLCγ pathways. In contrast dimerization of p75NTR
with sortilin allow high affinity binding of the pro-forms of the neurotrophins. The
Ras/MAPK pathway gets subsequently activated, finally leading to apoptosis by
JNK3 and caspase pathways. Interactions of the p75NTR with the Nogo receptor
and Lingo–1 participate in the control of neuronal growth. The RhoA activation and
a concurrent suppression of Rac leads to collapse of neuronal growth cones, neurite
retraction and also leads to reduction in spine density.
1.3.3 Neurotrophins participating in immunological functions
During the development of the CNS p75NTR plays an important part in neuron
selection and while the nervous system matures, p75NTR gets substantially down
regulated. However, it has been published that p75NTR expression can increase
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profoundly in response to disease or injury, highlighting a considerable role of the
neurotrophic system in regulating nervous system function in a healthy as well as
in a pathological state (Ibanez and Simi, 2012; Kraemer et al., 2014; Meeker and
Williams, 2014).
Increased expression of p75NTR on macrophages and microglia during pathological
states (Meeker and Williams, 2014) reveals a relatively unexplored area which may
ultimately influence our understanding of neuroinflammation. Detailed research on
p75NTR function in microglia and macrophages has yet to be published but indi-
cated by the presence of Trk receptors, NOGO receptors and sortilin, similar signal
transduction pathways as present in neurons could be involved. Several studies
suggest that macrophage/monocyte chemotaxis in the CNS may be regulated by
neurotrophins (Fry et al., 2007; David et al., 2008; Yan et al., 2012).
Additionally activated macrophages/microglia potentially release neurotrophins
(Heese et al., 1998; Srinivasan et al., 2004). This could either provide an autocrine
signaling pathway or raise the possibility of a direct signaling link between CNS
and immune system.
1.3.4 Microglia express and release neurotrophins
Microglia release several factors that are contributing to neuronal health and sur-
vival including neurotrophins (NGF and BDNF) and glial-derivedneurotrophic fac-
tor (GDNF) (Mallat et al., 1989; Elkabes et al., 1996; Wang et al., 2013). Both
microglia and macrophages produce NGF early in development in vivo (Frade and
Barde, 1998), while increased secretion of BDNF upon neuronal damage has also
been reported in vitro (Lai and Todd, 2008). This suggests that in response to
CNS insult microglia may upregulate neurotrophin release in support to neuronal
health. The regulation of BDNF synthesis and release in microglial cells appear to
be associated with the purinergic receptor P2X4R (Ulmann et al., 2008; Beggs et
al., 2012).
In a study by Parkhurst et al. (2013) the BDNF locus was deleted exclusively in
microglial cells, by crossing BDNF floxed mice with CX3CR1-CreER and treated
with tamoxifen to induce BDNF depletion during the desired time frame. These
mice were additionally crossed with Thy1-eYFP mice in order to visualize neuronal
structures and analyze dendritic spines with in vivo imaging. The experiments re-
vealed that after removal of microglial BDNF a significant decrease in the formation
rate of dendritic spines was induced. Unexpectedly these findings revealed a role
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for microglial cells in spinogenesis and synapse formation in the healthy CNS.
The microglial release of BDNF also mediates synaptic plasticity in a mouse
model of neuropathic pain (Coull et al., 2005). The function of microglial BDNF is
established in mediating pain in the spinal dorsal horn (Trang et al., 2011), but the
immunological effects of BDNF or microglial TrkB receptor activation are less clear.
Asami et al. showed in 2006 that BDNF treated macrophages increased phagocy-
tosis and upregulates IL-1β secretion. Given the similarities of macrophages and
microglia, similar effects could be present in these.
1.4 Toxoplasma gondii - a protozoan in the
central nervous system
Toxoplasmosis is an infection by Toxoplasma gondii (T. gondii), an obligate intra-
cellular, microscopic protozoan, so named after the organism it was first identified
in 1907 in North African rodents called gondis (Ctenodactylus gundi). T. gondii
belongs to the phylum Apicomplexa, subclass coccidia. It can take several differ-
ent forms: the oocyst; the tachyzoite; and the bradyzoite containing cyst. The T.
gondii genome usually is haploid, except during sexual division in cats, and con-
tains about 8x107 base pairs. In its attempt to conceal it’s presence from the host’s
immune response it invades the CNS and its cells. Following sections will introduce
the current understanding of the mechanisms important for this thesis.
1.4.1 Epidemiology of a world wide pathogen - T. gondii is
omnipresent
T. gondii can infect all warm blooded animals, namely mammals, including hu-
mans, and birds. As T. gondii is present in migratory birds, the parasite exits
on every continent but Antarctica. Humans most often acquire the infection by
ingesting oocysts or tissue cysts. Cat feces are the usual source of oocysts, while
tissue cysts are commonly found in undercooked meat. Cat feces contaminated
soil and water can act as vehicles, transferring the oocysts to vegetables and fruits
meant for human consumption.
The parasites sexual life cycle occurs in the intestine of felidae (the family of
the cats), the definitive hosts, which subsequently shed infectious oocysts with
their feces. Mammals and birds feeding off the ground become infected. Tissue
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cysts remain in brain and muscle until the intermediate host gets eaten by a cat,
thereby completing the life cycle. Ground-feeding livestock can become infected and
consequently become sources of infection for humans. T. gondii can be transferred
to a new host by infected donor organs. Fetuses can be infected via the mother’s
bloodstream in utero if the mother develops a primary infection during pregnancies.
In immunocompetent hosts the risk of developing an encephalitis during primary
Toxoplasmosis is negligible: 10-50% of North American citizens and up to 80%
people in Central America have measurable antibody titers against T. gondii and
no history of a disease. In the moist tropical places of South America, almost 100%
of the population over age 45 years could be positive for antibodies. Approximately
10% of immunocompetent individuals have clinical signs and symptoms, which are
usually mild, upon acute T. gondii infection.
The risk of in utero infection is highest if T. gondii infection is acquired shortly
before delivery. In HIV infected patients (with acquired immune deficiency syn-
drome (AIDS)) with T. gondii antibody, the risk of recurring active toxoplasmosis
is given at the time CD4+ cell counts fall below 200 per mm3.
1.4.2 Pathophysiology in humans
Figure 1.6: Toxoplasma gondii cyst - Elec-
tron micrograph of a disrupting bradyzoite cyst
in the CNS of a mouse chronically infected with
T. gondii. Remnants of the cyst’s wall (CW)
and spreading parasites (P) can be distinguished.
Note the influx of numerous macrophages (Ma).
Scale bar is 10µm (Micrograph from Ferguson
JP et al., 1989).
As previously mentioned T. gondii are
common infections in humans, and typi-
cally without severe symptoms because
adaptive immunity is acquired swiftly
to the widely spreading and multiply-
ing tachyzoites.
There are certain exceptions to the
above-mentioned asymptomatic pro-
gressions: in immature fetuses, im-
munocompromised patients or when the
infection takes place at immune privi-
leged body parts, e. g., brain or eye. De-
layed adaptive immune response leads
to a higher strain of the host’s organ-
ism. As adaptive immunity develops,
encysted bradyzoites colonize the tissue (brain, muscle, testicles). In immunocom-
promised patients cysts that rupture leave necrotic tissue and the freed bradyzoites
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reverse their transformation back into tachyzoites that multiply and injure tissue.
1.4.3 T. gondii entering the brain through the blood brain
barrier
1.4.3.1 The blood brain barrier
Besides the blood-brain barrier (BBB) the CNS contains two more main barrier
sites, the arachnoid epithelium and the epithelium of the choroid plexus. The BBB
is built by highly specialized microvascular endothelial cells, forming a functional
and structural barrier with low permeability, limited pinocytosis activity, lacking
endothelial pores (fenestrations), and high transendothelial resistance (Abbott et
al., 2006).
Figure 1.7: Barrier sites in the CNS - (1) The blood-brain barrier is formed by endothelial
cells in the brains capillary system. (2) At the choroid plexus epithelial cells the
barrier between the blood and the cerebrospinal fluid exists. (3) The arachnoid
epithelium protects the cerebrospinal fluid. The intercellular between endothelial
and epithelial cells spaces are sealed by tight junctions (Adapted from Feustel et al.,
2012).
Surrounding cells like microglia and astrocytes interact with the cells the BBB is
composed off and support the maintenance of the barrier and its functions by releas-
ing soluble agents such as transforming growth factor-β (TGFβ), basic fibroblast
growth factor (bFGF) and glial-derived neurotrophic factor (GDNF). Intracellu-
lar cAMP elevating signaling molecules (like adrenomedullin) and hydrocortisones
decrease the permeability between cells and strengthen barrier. To the contrary
reactive oxygen species (ROS), inflammatory cytokines (IL-1, IL-6, TNF) , nitric
oxide (NO) and other mediators impair the impermeability of the BBB. Adherence
junctions and tight junctions restrict hydrophilic molecules to fluctuate between
cells and limit the migration of the various cell types through the endothelial bar-
rier (Deli et al., 2005; Haseloff et al., 2005; Dohgu et al., 2005).
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Regardless of this cellular mechanics, there exist several pathways for molecular
trafficking across the BBB. E. g., the lipid membranes of the endothelium permit the
diffusion of lipophilic agents (Abbott et al., 2006). Also, there are specific receptors
(e. g., transferrin and insulin receptors), which transport their ligands through the
endothelium by means of receptor-depended endocytosis and exocytosis. As the
brain needs to be provided with nutrients and other substances transport proteins
for glucose, amino acids, purine bases and nucleosides are included in the BBB while
the transport protein P-glycoprotein is an eﬄux pump that actively transports
lipophilic drugs out of endothelial cells (Löscher and Potschka 2005).
During inflammation blood stream circulating leukocytes crawl across the en-
dothelial barrier into the CNS (Ley et al., 2007). This migration follows a specific
sequence adhesion and extravasation steps, allowing to cross the extracellular ma-
trix, basal lamina and the endothelial barrier (Rahman and Fazal, 2008). Leuco-
cytes express P-selectin glycoprotein ligand 1 (PSGL-1), which is a ligand for E- and
P-selectin, which are in turn expressed by endothelial cells (Kansas, 1996). Leuko-
cyte extravasation involves a paracellular or a transcellular route with different cell
signaling pathways included (Zarbock et al., 2009).
1.4.3.2 Dissemination and Neuroinvasion of T. gondii
The tachyzoite form of T. gondii are effected by several aspects of the host’s adap-
tive immune response. Whilst IgG against T. gondii in sera mediate parasite lysis
T. gondii specific IgM inhibit tachyzoites from invading host cells. To protect itself
against the immune system an intracellular habitat for T. gondii poses a mandatory
solution for survival and subsequent dissemination.
T. gondii lacks flagella or cilia for locomotion (Soldati and Meissner, 2004; Wetzel
et al., 2002). Invading host cells is anyhow achieved without the host cells cooper-
ation (Morisaki et al., 1995; Carruthers et al., 1999). After gaining proximity by
gliding motility, the invasion itself is mediated by the secretion of a subset of par-
asite proteins into the host cells. These micronemal proteins (MICs) are apically
exocytosed into the host cell. MIC2 is also displayed apically, binding the cell adhe-
sion molecule ICAM-1, to anchor the parasite to the host cell (Dowse and Soldati,
2004). T. gondii infection induces the expression of different adhesion molecules
and cytokines in host cells: brain endothelial cells upregulate 2 h post infection
ICAM-1 expression while the chemokine MCP-1 is expressed 12 h post infection
(Lachenmaier et al., 2011). Upregulation of adhesion molecules and proinflamma-
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tory chemokine secretion seem to be important parts of host cells response to T.
gondii infection.
1.4.3.3 T. gondii as a model for neuroinflammation
Toxoplasmic encephalitis is one of the most prominent opportunistic infections in
immunocompromised patients. When not kept low by the immune system it can
cause severe brain injury, coma and even death (Osunkalu et al., 2011). Especially in
patients with AIDS, the pathogen is responsible for lesions and necrosis in different
parts of the CNS (e.g., substantia nigra, ventral striatum, ventral pallidum). Al-
ready slightly immunocompromised patients may develop neurological symptoms;
additionally to anxiety, depression and schizophrenic episodes (El Lakkis et al.,
2015).
Nevertheless, even in immunocompetent patients bradyzoites within the neurons
produce a protein, which is functionally homologues to tyrosine hydroxylase and
thereby being able to manipulate dopamine synthesis and also the release (Pran-
dovszky et al., 2011). This raises the possibility that by changing dopamine levels
T. gondii actively interferes with the behavior (Money and Stanwood, 2013).
Moreover, the parasite also stimulates the secretion of cytokines (IFN-γ and
IL-12) and initiates NFκB signal pathways via MAPK (Kim et al., 2004). This
establishes a stable host-parasite interaction (Vallochi, 2008). IFN-γ is seen to
be the most important cytokine, released by T-cells which invade the CNS upon
infection (Schlüter et al., 1995). Beyond T-cells, B-cells (Schlüter et al., 1998), NK
cells (Schlüter et al., 1995), macrophages (Suzuki et al., 2005), and dendritic cells
(Fischer et al., 2000) also cross into the CNS upon infection.
T. gondii infection induces a variety of other cytokines (e.g., IL-1 and TNF-α; IL-
10 and TGF-β) by neurons, astrocytes, and microglia (Fischer et al., 1997; Schlüter
et al., 1997, 2001). T. gondii actively blocks TNF-α expression in monocytes by
blocking the host’s chromatin structures and inhibiting promoter - transcription
factor interaction (Leng et al., 2009). Inducing anti-inflammatory cytokines, such
as TGF-β, IL-10 and IL-27 are thought to prevent tissue destruction by balancing
Th1/Th2 response (Damsker et al., 2010).
Several CNS cells, including neurons, astrocytes, and microglia, are invaded by
T. gondii (Jones et al., 1986; Chao et al., 1993; Fischer et al., 1997; Halonen et
al., 1998). The recognition of the parasite in these cells has been connected to the
toll-like receptor 11 (TLR11), generating various downstream immune responses
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(Atmaca et al., 2014).
The general importance of inflammatory mediators in neurodegenerative disease
and brain disorders has been a documented intensely for schizophrenia, brain injury,
depression and bipolar disorders (Parlog et al., 2015; Stich et al., 2015).
Considering the broad adaptability of T. gondii to its many possible hosts, as
well as its potential to immunomodulate, this pathogen is a great model to study
CNS - immune system interactions.
1.5 Aim of the study
As previously outlined, there is plenty of evidence that neurotrophic factors play a
major role in the regulation of immunological response to pathological events within
the central nervous system (c.f. section 1.3.3). Intriguingly it is also known that
the p75NTR is not only important in a broad variety of signalling pathways within
neurons, by its potential to bind all neurotrophins and form heterodimers with the
other receptors (c.f. section 1.3.2), it is also expressed on several immunological
active cells and its expression is increased during different pathological states. The
role of p75NTR in this context is yet unclear.
To elucidate the role of the p75NTR in chronic CNS inflammation, the proto-
zoan parasite Toxoplasma gondii was used for its natural occurrence in human and
the scientific model organism of choice, the mouse, alike (c.f. section 1.4). The
characterization of hippocampal and cortical neurons depending on the presence of
the p75NTR in context of a persistent T. gondii infection is a novel step to gain a
deeper understanding of neurotrophic contribution to neuroinflammation. Also, the
possible change of the quantity of neurotrophin receptors upon T. gondii infection
is of interest. Additional to neuronal reaction microglial reaction to the parasite,
representing the CNS immune system, is to be characterized morphologically to
gain broader insights into the interleaving connections between CNS and immune
system by p75NTR.
Another question is whether the C57BL/6 (B6) mouse strain infected with T.
gondii is an appropriate model for chronic toxoplasmosis - by comparing results to
another mouse strain (BALB/c).
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2.1 Mouse strains and T. gondii infection
The p75NTR exonIV knockout mouse generated by von Schack et al.(2001) were
crossed into C57BL/6-Thy1 -eGFP line M mice (Feng et al., 2000) and used for the
analysis of neuronal architecture. For biochemistry experiments, p75NTR exonIV
knockout mice not expressing eGFP were used. Additionally BALB/c animals were
used. In this thesis, only female mice have been analyzed.
Except for the BALB/c mice, all mice have been bred and housed at the animal
facility of the TU Braunschweig until the age of 8 to 12 weeks. Then they have
been transported to the animal facility of the Otto von Guericke Universität in
Magdeburg and been infected with T. gondii (cf subsection 2.1.1).
All animals were housed at a standard day-night cycle of 12:12 h, at ≈ 22 °C with
4-5 animals each cage. Food and water were provided for ad libitum.
2.1.1 Infecting mice with Toxoplasma gondii cysts
Infections with the protozoan Toxoplasma gondii were carried out and planned by
Dr. Ildiko Dunay and colleagues at the Institute of Medical Microbiology, Otto
von Guericke University Magdeburg. Female mice (8-12w old, cf section 2.1) were
infected with 2 cysts of the T. gondii strain ME49 type II. For this means a pre-
viously infected (4-5 months prior) NMRI mouse was sacrificed, and the isolated
brain was homogenized in 1ml PBS.
Cyst concentration was determined by counting the number of cysts within 10µl
homogenate under a light microscope. After repeating this step at least three times,
the total concentration was calculated. Two cysts were then administered to each
mouse intraperitoneally (i.p.) in a total volume of 200 µl (diluted in PBS). Control
mice received 200 µl PBS instead.
Infected mice and healthy controls were kept in the same room at a standard
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day-night cycle of 12:12 h, at ≈ 22 °C with 4-5 animals each cage. Food and water
were provided for ad libitum.
2.1.2 Genotyping of transgenic mice
To verify the lack of the forth exon of the p75NTR gene and the inclusion of the
eGFP construct (cf section 2.1) genomic DNA was extracted from tail tips. This
small amount of tissue was digested on a shaker (650 rpm) in 500 µl lysis buffer
(containing proteinase K) at 55 °C overnight. The DNA was cleared from cellular
debris by centrifugation with 14000 x g for 10 min. Afterwards, the DNA was
precipitated with 500 µl isopropanol, and the resulting pellet washed with 70%
ethanol.
The DNA was stored in 10mM Tris/ HCl (pH8) at -20 °C. 3µl of genomic DNA
were used for one polymerase chain reaction (PCR) to detect the presence or absence
of the above-mentioned genes (cf table 2.2). Results were visualized via agarose gel
electrophoresis. Table 2.1 contains detailed information about the used primers.
Table 2.1: These primers were used for genotyping. All primers were pre-diluted 1:5 before using
in a PCR.
Gene sequence tag sequence
p75NTR 1 AAGGGGCCACCAAAGAACGG
2 GTTGGAGGATGAATTTAGGG
3 GATGGATCACAAGGTCTACGC
eGFP sense AAGTTCATCTGCACCACCG
anti-sense TGCTCAGGTAGTGGTTGTCG
Thy1 Thy1 F1 (forward) TCTGAGTGGCAAAGGACCTTAGG
Ey PP RI (reverse) GCTGAACTTGTGGCCGTTTACG
TrkB-Tk+/T1 TrkB (upper) CTCCCACTTCCTTGGCTT
TrkB (lower) GCCCCACGTAAGCTTCGA
2.2 Perfusion and brain dissection
In order to preserve neurons in their ex vivo state mice were deeply anesthetized
by placing the mice in a glass beaker with an isoflurane soaked paper tissue. In
order to confirm the genotype the tip of the tail was cut and frozen (-20 °C). Then
24
2.3 DiOlistic labeling
Table 2.2: Following components were included in every PCR mix.
Component volume
DNA-Sample 0.5µl
Taq-Buffer 5 µl
dNTP’s (10mM each) 0.5 µl
Primers (cf table 2.1) 0.5 µl each
Taq polymerase 0.25 µl
MgCl2 3µl
Aquapurificata 14.25µl
the abdominal cavity was opened and the transcardial perfusion with ice cold 4%
PFA in 0.1M PB was performed by inserting a needle into the left ventricle and
opening the right atrium to allow the liquid to flow through the entire circulation.
The cranium was opened and the brain removed, the cerebellum cut away and the
hemispheres divided.
Hemispheres meant for immunohistochemistry (cf section 2.4) were post-fixed
in ice cold 4% PFA in 0.1M PB for 30min, briefly washed in PBS and subse-
quently put into 30% sucrose in 0.1M PB and stored for 3 d at 4 °C to dehydrate
them. Afterwards, these hemispheres were embedded in Tissue-Tek® O.C.T. TM
(A.Hartenstein Laborversand) and stored at -80 °C until being further processed.
Hemispheres meant for spines analysis, and neuronal morphological analysis (cf
section 2.5) were postfixed in ice cold 4% PFA in 0.1M PB for half an hour and
subsequently stored in PBS. These hemispheres were then cut with a vibratome
(Leica, VT1000S) into 150µm and 300 µm sections and mounted on glass slides
with Fluoro-Gel mounting medium (EMS; 17985-10) and imaged within one week.
For biochemical experiments (cf section 2.6) the mice were sacrificed by cervical
dislocation, the brain removed and quickly dissected into hippocampus (HC) and
cortex (C). The different parts were put in weighted reaction vessels and flash
frozen in liquid LN2. Afterwards, the samples were stored in the freezer (-20 °C)
until being further processed.
2.3 DiOlistic labeling
Hippocampal and cortical neurons of BALB/c mice were labeled utilizing DiOlistics
on PFA fixed brain sections. For this purpose, DiI bullets were prepared with
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tungsten particles (50mg; Ø 0.7 µm, 1.7 µm) spread on a glass slide. These particles
were then mixed with 100µl dye solution (3mg DiI dissolved in 100 µl methylene-
chloride; Invitrogen, Sigma-Aldrich). Methylene-chloride evaporates rapidly at RT.
The DiI coated tungsten was then scratched off the glass slide with a razor blade
and suspended in 3ml Aquapurificata, vortexed and sonicated. Dilutions of 1:20, 1:30,
1:40 and 1:50 were used to coat TEFZEL tubes (Bio-Rad). These bullets can be
stored in the dark at RT for months. Hemispheres were then cut with a vibratome
(Leica, VT1000S) into 400 µm coronal sections and post-fixed with 4% PFA and
4% sucrose in 0.1M PB for 1 h. After washing briefly with PBS, 3-4 sections were
placed within a tissue-culture insert (Merck Millipore).
The DiI-tungsten coated bullets were loaded into a gene-gun (Bio-Rad) and shot
at the sections from a distance of roughly 1.5 cm with a pressure of ≈ 8200 hPa
(120 psi). In order to prevent clusters of DiI coated particles to reach the sections
and protect the section from direct exposure to the pressur,e a membrane filter
(Ø 3µm; Merck Millipore) was held between the gene-gun and the sections. The
sections were kept in PBS overnight at RT. During this time the lipophilic DiI
diffused on the membranes of cells. The day after the sections were quickly checked
visually to confirm the success the of the shootings the prior day with a fluorescence
microscope (Axioplan 2 microscope; Zeiss). Consecutively sections were stained
with DAPI solution 1:1000 (1mg/ml in PBS) for 10min and mounted on glass
slides with Fluoro-Gel mounting medium (EMS; 17985-10) and imaged within one
week, because of the rapidly increasing background.
2.4 Immunohistochemistry
The hemispheres (cf section 2.2) were mounted on a freezing microtome (≈ -30 °C)
within a frozen block of Tissue-Tek® O.C.T. TM (A.Hartenstein Laborversand).
The 30 µm sections were collected in PBS and afterwards were incubated in a
blocking and permeabilizing solution (cf table 2.3) for 1 h at RT on a shaker to
permeabilize the membrane and saturate unspecific binding sites. Section were
then incubated with the primary antibody (cf table 2.4) diluted in PBS with 0.2%
Triton X-100 and 10% goat serum at 4 °C covered in plastic wrap on a shaker
overnight. Additionally a 30min of incubation at RT took place on a shaker. That
sections were then washed 3 x with PBS for 10min at RT on a shaker. Secondary
antibodies were diluted in PBS and incubated at RT for 2 h and in the dark on a
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Table 2.3: The blocking solution for immunohistochemistry is prepared in sterile PBS. It
can be stored in -20 °C for several weeks.
Substance concentration
Goat serum 10%
BSA 1%
Triton X-100® 0.2%
shaker.
Table 2.4: The following table contains all antibodies used for immunohistochemistry
staining in 30µm sections.
Antigen Clonality Organism Work dilution Source
CD11b monoclonal mouse 1:250 abcam® ab64347
F4/80 monoclonal rat 1:1000 abd Serotec®
Iba-1 polyclonal rabbit 1:1000 Synaptic Systems
Mouse/rabbit
Cy2/Cy3/Cy5
monoclonal goat 1:500 Jackson Immuno Res.
A DAPI-solution (1mg/ml in PBS) 1:1000 was applied for 5min and then the
sections were washed 4 x with PBS for 10min at RT on a shaker. Then the sections
were mounted on glass slides with anti-fading aqueous Fluoro-Gel mounting medium
(EMS; 17985-10).
2.5 Imaging
2.5.1 Image acquisition and analysis for neuronal architecture
B6Thy1-eGFP and B6Thy1-eGFP-p75NTR/ExonIV-/- mice were analyzed 4 weeks and 8
weeks post T. gondii infection (cf section 2.1).
EGFP expressing neurons were imaged using an Apotome® (Zeiss) equipped
Axioplan 2 microscope (Zeiss). To reconstruct dendritic architecture a 20 fold 0.8
NA Plan-APO objective (Zeiss, 0.32 µm per pixel) was used to acquire hippocam-
pal CA1 neurons. Controlled by the Axiovision® software (Zeiss) a z-stack step
distance of 1µm was achieved.
To simplify the analysis isolated, not overlapping eGFP expressing hippocampal
CA1 neurons were chosen. Morphological analysis and reconstruction ("tracing")
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were accomplished by using Neurolucida® version 6 and Neurolucida Explorer®
software version 4.50.3 (Microbrightfield Bioscience).
Sholl analysis was used to quantify dendritic arborization. The software draws
concentric circles around the soma at increasing distance and counts the number of
intersections with dendrites for each circle. Raw values were exported to GraphPad
Prism 6. For total complexity, the raw values obtained from the Sholl analysis were
added to each other for each neuron. In comparisons between two data sets unpaired
two-tailed Student’s t-test was utilized. Comparing three or more data sets was
done by ordinary one-way ANOVA with Tukey’s post hoc test. P values of less than
0.05 were considered significant and plotted as follows: * = p < 0.05; ** = p <
0.01; *** = p < 0.001; **** = p < 0.0001. The n plotted refers to the number of
cells analyzed, at least three animals per category were analyzed.
2.5.2 Image acquisition and analysis for dendritic spines
Dendrites of eGFP expressing hippocampal and cortical neurons were imaged using
a laser scanning confocal microscope (Olympus, BX61WI FluoView 1000). A 40
fold oil objective (NA 1.3) and a z-step size of 0.35µm were used. Depending on
how straight a dendrite was an image of a variable vertical size (128-512) pixels
times a horizontal size of 1014 pixels was used in a 6 fold zoom resulting in final
pixel sizes ranging from 72 nm to 65 nm respectively.
As the background in slices labeled by Diolistic tents to fastly increase. These
samples were imaged as fast as possible with as lowest a laser intensity as possible
while trying to avoid dendrites which extend deep into the z-axis.
Raw confocal images (oif.-files) were deconvolved using AutoQuantX2 (Media
cybernetics, Inc.; TIFF-files) and analyzed with ImageJ (US National Institutes of
Health). The length of dendrites was determined with the segmented line tool, and
the number of spines was calculated with the multipoint selection tool. Raw values
were exported to GraphPad Prism 6 for statistical analysis. The n plotted refers to
the number of animals analyzed. Per animal and region, 5 dendrites were analyzed
and averaged. In comparisons between two data sets unpaired two-tailed Student’s
t-test was utilized. Comparing three or more data sets was done by ordinary one-
way ANOVA with Tukey’s post hoc test. P values of less than 0.05 were considered
significant and plotted as follows: * = p < 0.05; ** = p < 0.01; *** = p < 0.001;
**** = p < 0.0001.
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2.5.3 Image acquisition immunohistochemistry
Additionally to the neuronal response to the T. gondii infection the phenotype of
microglia upon T. gondii infection was characterized. For this purpose microglia
cells/macrophages were labeled with an anti-Iba1 antibody (cf section 2.4). Images
of the stratum radiatum and dentate gyrus within the CA1 area of the hippocampus
and the cortex were taken with a 20 fold 0.8 NA Plan-APO objective (Zeiss, 0.32 µm
per pixel) with a z-sectioning of 1 µm at an Apotome® (Zeiss) equipped Axioplan
2 microscope (Zeiss). Iba1+ cells were then counted in overlap with the DAPI
signal. Per area and animal three regions of interest (ROIs) were analyzed. The n
plotted in the results is the number of ROIs.The multipoint tool of ImageJ (V1.49
US National Institutes of Health) was used. Data were analyzed with GraphPad
Prism 6.01 as mean ± SEM. In comparisons between two data sets unpaired two-
tailed Student’s t-test was utilized. Comparing three or more data sets was done
by ordinary one-way ANOVA with Tukey’s post hoc test. P values of less than 0.05
were considered significant and plotted as follows: * = p < 0.05; ** = p < 0.01;
*** = p < 0.001; **** = p < 0.0001.
2.6 Biochemical methods
2.6.1 Brain lysates
Tissue was weighed frozen and thawed on ice. The weight in mg was used to
determine the amount of brain lysate buffer (cf Table 2.5), equaling the amount
of mg in µl. The tissue was homogenized with a pestle and dissociated with the
tip of an ultrasonic processor (Hielscher UP50H; cycle 1; 80% amplitude). The
ultrasonic tip was briefly applied for 5 s and then cooled down on ice again. This
step was repeated four times. When tissue was still attached to the pestle 1
4
of
the initial buffer volume was used to rinse it. The resulting lysate was centrifuged
for 1.5 h at 4 °C with 15500 x g (Servall® Hereaus Biofuge primoR; rotor: 7599B).
The supernatant was divided into 15µl aliquots and stored at -20 °C until further
processed.
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Table 2.5: The brain lysis buffer can be stored at 4°C for several months. The pH is to be
adjusted to 7.3 at this temperature. This buffer contains distinct levels of Triton
X-100® and therefore cannot be used directly in a Bradford protein assay. Sam-
ples must be diluted at least 1:5 with PBS before determining protein concentration.
Protease inhibitors should always be applied to the mixture immediately before ho-
mogenization.
Substance concentration
HEPES 50mM
NaCl 150mM
EGTA 2mM
Triton X-100® 0.5%
AEBSF 0.4mM
Pepstatin A 2 µM
Trasylol (Aprotinin) 1%
2.6.2 Bradford assay
Protein concentrations within the different brain lysates were determined using
protein the Bradford protein assay. A calibration curve was derived from several
dilutions of a 1mg/ml BSA in PBS solution.
Protein dilutions ranging from 1:100 to 1:800 were prepared and duplicates were
measured and their mean used in calculations. 20 µl of each dilution was mixed
with 100 µl Bradford solution in a 96-well plate and incubated for 5min at RT. The
following readout via ELISA at 595 nm, the protein concentration was calculated
referring to the BSA calibration curve (linear regression analysis).
Table 2.6: The Bradford protein assay reagent was prepared with Aquapurificata. The blow men-
tioned amounts suffice for 1 l. When stored under dark conditions the Bradford
reagent can be used for several years. Freshly prepared Bradford reagent needs to
be filtered.
Substance concentration
Coomassie Brilliant Blue G-250 100mg
Ethanol 50ml
Phosphoric acid 85% (v/v) 100ml
2.6.3 SDS-PAGE
The gels were prepared by mixing and chemically linking acrylamide and bisacry-
lamide (crosslinker; ratio 37.5:1). The polymerization was started by ammonium
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persulfate (APS; source of free radicals) and catalyzed by TEMED (N,N,N,N’-
tetramethylenediamine). The detailed gel composition is listed in Table 2.8. Protein
samples were boiled (100°C; 5min) before electrophoresis with SDS. Additionally
β-mercaptoethanol was added to reduce disulfide bonds (cysteine residues) result-
ing in a complete denaturation of the proteins. In order to get sharper, well defined
bands a discontinuous system usually was applied (cf table 2.7). The stacking gel
atop the separation gel had a pH of 6.8. The power supply was set for 240V and
10mA until the sample was in a thin line, indicated by the bromphenol blue band,
which is part of the loading buffer. Afterwards, the electric current was raised to
20mA and kept constant until the end of the electrophoresis.
Table 2.7: Discontinuous SDS-PAGE need two different gels and these need to have different
buffers to work..
Buffer SDS Tris pH
Separation gel buffer 0.4% 1.5mol/l 8.8
Stacking gel buffer 0.4% 0.6mol/l 6.8
Table 2.8: The aqueous 30% acrylamide bisacrylamide ready-to-use stock solution Rotiphorese®
Gel 30 (Carl Roth; 37.5:1) was used in several concentrations. The here specified
quantities suffice for 11 gels. Gradient gels comprised of half the below mentioned
amount for each concentration.
Substance 4% gel 10% gel 20% gel stacking gel
Aquademin 74ml 50ml 10ml 46,5ml
Separation gel buffer 30ml 30ml 30ml
Stacking gel buffer 25ml
Rotiphorese® Gel 30 16ml 40ml 80ml 13ml
TEMED (SERVA) 50µl 50µl 50µl 50µl
APS (10% (w/v)) 800µl 800 µl 800 µl 1000µl
2.6.4 Western Blot (Towbin et al., 1979; Burnette, 1981)
and ECL reaction
Before proteins can be labeled and identified with antibodies, they need to be verti-
cally transferred and immobilized on a polyvinylidene fluoride membrane (Rothi®
Flouro PVDF; Roth) while preserving the separation pattern the tank-blot variance
( ∧= wet blot) of Western blotting was applied (Biometra 013-300). Therefore the
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sandwich cassette was placed between the two electrodes in a pre-cooled buffer (cf
Table 2.10) filled tank (cf Figure 2.1). This tank was then placed in a crushed-ice
filled box and kept in the cool room (4°C) overnight. The power supply was set to
35V and 200mA per gel. To verify the majority of the protein within the gel trans-
ferred to the membrane the gel was stained with coomassie to visualize remnant
protein (cf table 2.9).
Table 2.9: The following components suffice for 2 l of the Coomassie staining solution.
Substance concentration
C2H4O2 200ml
C3H8O 500ml
Aquapurificata 1300ml
Coomassie 0.5 g
The PVDF membrane was incubated in 5% skim milk powder diluted in TBS-T
for one hour at RT on a shaker to block free binding sites and afterward washed 3
times with 1 x TBS-T for 10min each.
Table 2.10: The blotting buffer was prepared a day ahead of the experiment and stored at
4°C.
Substance concentration
Methanol 20%
SDS 0.05%
EGTA 2mM
Glycine 1.5mol/l
Tris 0.25mol/l
10x blot buffer stock 10%
Table 2.11: The TBS-T was prepared as 10 fold stock solution in Aquapurificata. The pH was
adjusted to 7.6 with HCl.
Substance concentration
NaCl 150mM
Tris 50mM
Tween-20 0.05%
The Membrane was then cut to remove the overhang above the original gel size
and to divide the protein of interest from the internal standard horizontally. Sub-
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Figure 2.1: Schematic diagram of the Tankblot including the blot-sandwich. Instead of nitrocel-
lulose a PVDF membrane was used in this thesis. Image taken from the Biometra
manual.
sequently the membrane pieces were incubated with diluted primary antibodies (cf
Table 2.12) over night at 4°C in a 10ml falcon tube on a rotating wheel, and subse-
quently washed 3 times 10min with 1 x TBS-T for removing unbound antibodies.
Incubation with the secondary antibody (goat anti mouse/rabbit IgG HRP conju-
gated, cf Table 2.12) took place at RT for at least 1 h. The following washing steps
differ from the previous by washing two times with TBS-T for 10min at RT and
once with TBS-X for 1min at RT. The membrane was then put into Aquademin for
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5min to wash off the remains of the Triton X-100®.
Table 2.12: The following antibodies were used in Western blots. Each was diluted in 1x TBS-T
and incubated on a rotating wheel.
Antigen clonality supplier and reference number concentration
p75NTR rabbit monoclonal abcam ab52987 1:50000
p75NTR rabbit polyclonal abcam ab38335 1:1000
TrkB rabbit polyclonal Milipore 07-225 1:2000
α-Tubulin mouse monoclonal Sigma-Aldrich® T9026 1:10000
GAPDH rabbit polyclonal Acris AP21839PU-N 1:3000
Following LuminataTM Crescendo HRP substrate solution was applied directly
onto the membrane for 2min. In a darkroom, the emitted light was detected
with X-Ray films (LucentBlueTM; Pierce). After developing and fixing the films
in the dark, they were dried at RT and then scanned (600 dpi). The densiomet-
ric analysis was performed with the freely available GelAnalyzer2010a software
(www.gelanalyzer.com). Per animal 3 repetitions were analyzed and every repeti-
tion consisted of triplets. In comparisons between two data sets unpaired two-tailed
Student’s t-test was utilized. Comparing three or more data sets was done by ordi-
nary one-way ANOVA with Tukey’s post hoc test. P values of less than 0.05 were
considered significant and plotted as follows: * = p < 0.05; ** = p < 0.01; *** =
p < 0.001; **** = p < 0.0001.
As loading controls, α-Tubulin and GAPDH (Glyceraldehyde 3-phosphate dehy-
drogenase) were used. These proteins are constitutively expressed at high levels
in almost all tissues and cell lines making them ideal for use as loading control
markers in immunoblots.
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In this work the effect of chronic Toxoplasma gondii infection, as a model for direct
immune insult and prolonged neuroinflammation, on B6 wild type and p75NTR
knock out mice, was analyzed. Additionally, mouse strain specific differences in
the effect of the parasite infection were analyzed by comparing the results from
the B6 mouse strain to the BALB/c mouse strain. The following sections will
include results about neuronal architecture, dendritic spine densities, microglial
response and neurotrophin receptor expression upon Toxoplasma gondii infection
in the aforementioned mouse strains for 4 and 8 weeks after infection with T. gondii.
3.1 Morphological analysis of hippocampal and
cortical pyramidal neurons
Neuroinflammation caused by intraperitoneal infection with T. gondii tissue cysts
and subsequent invasion of the CNS has been shown to cause morphological changes
in hippocampal and cortical pyramidal cells (Parlog et al., 2014) in rodents.
However, the molecular mechanisms mediating these alterations and especially
the role of p75NTR and neurotrophins on the progression of the disease are still
unknown. In this study, the architecture of hippocampal CA1 neurons and cortical
layer V/VI pyramidal neurons were analyzed four and eight weeks after Toxoplasma
gondii infection. The dendritic complexity of the excitatory pyramidal CA1 neurons
was analyzed by the Sholl analysis for the apical and the basal dendrites (Sholl,
1953). Additionally, the spine density of these excitatory cortical and hippocampal
neurons was determined.
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3.1.1 Changes in dendritic complexity in T. gondii infected
mice
Parlog et al., have shown that upon T. gondii infection the dendritic architecture
of pyramidal neurons is altered. Significant reduction in complexity in the basal
tuft of cortex layer III neurons with a significantly decreased total dendritic length
were shown in the 2014 publication.
Table 3.1: Descriptive statistics for total complexity of CA1 dendrites in fig. 3.1
Genotype CNS area T. gondii Mean±SEM
B6 WT CA1 apical - 152.9±10.49 dendritic intersections
B6 WT CA1 apical 4w 133.3±4.708 dendritic intersections
B6 WT CA1 apical 8w 108.9±7.834 dendritic intersections
B6 WT CA1 basal - 125.2±6.895 dendritic intersections
B6 WT CA1 basal 4w 129.7±7.197 dendritic intersections
B6 WT CA1 basal 8w 86.41±5.45 dendritic intersections
Figure 3.1 shows how chronic T. gondii infection effects dendritic architecture of
hippocampal pyramidal CA1 neurons in B6 wt mice. Figure 3.1 A, A’ and A” show
reproductions ("tracings") of B6 wt CA1 neurons of control, 4w T. gondii infected
and 8w T. gondii infected mice. After 8w infected with T. gondii the amount of
dendrites is visibly reduced.
Figure 3.1 B and B’ show the results of the Sholl analysis (c.f. section 2.5.1) for
apical and basal CA1 neurons of control B6 wt versus 4w T. gondii infected B6 wt
mice. Both, the control and the 4w T. gondii infected, show a similar distribution
of dendritic complexity relative to the distance from the cell body.
Figure 3.1 C and C’ show the results of the Sholl analysis for apical and basal
CA1 neurons of control B6 wt versus 8w T. gondii infected B6 wt mice. The
curves do not overlap; the curves of the 8w T. gondii infected B6 wt mice show
a different distribution of dendritic complexity relative to the distance from the
cell body compared to the wt control for both, apical and basal, dendrites of the
hippocampal CA1 neurons.
Figure 3.1 D and D’ show the total complexity for control, 4w T. gondii infected
and 8w T. gondii infected B6 wt mice in CA1 neurons. For the apical dendrites
(fig. 3.1 D) no significant difference between the B6 wt control and the 4w T.
gondii infected B6 wt mice could be shown, also no statistical significant difference
between 4w T. gondii infected B6 wt mice and 8w T. gondii infected B6 wt mice
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Figure 3.1: Influence of a chronic Toxoplasma gondii infection with different incuba-
tion times on dendritic complexity of hippocampal CA1 pyramidal neu-
rons - (A, A’, A”) Exemplified morphology of hippocampal CA1 pyramidal neurons
of B6 control, 4w infected and 8w infected, scale bar is 100µm (B, B’) Dendritic
complexity of hippocampal CA1 pyramidal neurons (apical and basal tree), B6 con-
trol vs B6 4w infected with T. gondii (C, C’) Dendritic complexity of hippocampal
CA1 pyramidal neurons (apical and basal tree), B6 control vs B6 8w infected with
T. gondii (D, D’) Total complexity of hippocampal CA1 pyramidal neurons apical
and basal dendrites. B6 control vs B6 4w vs B6 8w infected with T. gondii. Data
presented as mean ± SEM. p***<0.001; p**<0.01; p*<0.05. The n represents the
number of cells analyzed, at least 3 animals per condition were used.
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can can be observed. The total complexity of B6 wt control versus 8w T. gondii
infected B6 wt mice shows a significant decrease in the total number of intersections
in the 8w T. gondii infected B6 wt mice.
For the basal dendrites (fig. 3.1 D’) no significant difference between the B6 wt
control and the 4w T. gondii infected B6 wt mice could be shown. Both, B6
wt control and 4w T. gondii infected B6 wt mice show significantly higher total
numbers of intersections than the 8w T. gondii infected B6 wt mice. Descriptive
statistics for fig. 3.1 are listed in table 3.1.
Table 3.2: Descriptive statistics for total complexity of CA1 dendrites in fig. 3.2
Genotype CNS area T. gondii Mean±SEM
B6-p75NTR-/- CA1 apical - 158.6±15.98 dendritic intersections
B6-p75NTR-/- CA1 apical 4w 155±7.785 dendritic intersections
B6-p75NTR-/- CA1 apical 8w 144.8±5.808 dendritic intersections
B6-p75NTR-/- CA1 basal - 133.2±7.468 dendritic intersections
B6-p75NTR-/- CA1 basal 4w 126.6±8.643 dendritic intersections
B6-p75NTR-/- CA1 basal 8w 115.8±7.306 dendritic intersections
Figure 3.2 shows how chronic T. gondii infection effects dendritic architecture of
hippocampal pyramidal CA1 neurons in B6-p75NTR-/- mice. Figure 3.1 A, A’ and
A” show reproductions ("tracings") of B6-p75NTR-/- CA1 neurons of control, 4w T.
gondii infected and 8w T. gondii infected mice.
Figure 3.2 B and B’ show the results of the Sholl analysis (c.f. section 2.5.1)
for apical and basal CA1 neurons of control B6-p75NTR-/- versus 4w T. gondii
infected B6-p75NTR-/- mice. Both conditions show a similar distribution of dendritic
complexity relative to the distance from the cell body.
Figure 3.2 C and C’ show the results of the Sholl analysis for apical and basal
CA1 neurons of control B6-p75NTR-/- versus 8w T. gondii infected B6-p75NTR-/-
mice. Both conditions show a similar distribution of dendritic complexity relative
to the distance from the cell body.
Figure 3.2 D and D’ show the total complexity for control, 4w T. gondii infected
and 8w T. gondii infected B6-p75NTR-/- mice in CA1 neurons. For the apical and
basal dendrites (fig. 3.2 D, D’) no significant difference between the B6-p75NTR-/-
control and both T. gondii infected B6-p75NTR-/- mice can be observed regarding
the total number of intersections. Descriptive statistics for fig. 3.2 are listed in
table 3.2.
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Figure 3.2: Influence of a chronic Toxoplasma gondii infection with different incuba-
tion times on dendritic complexity of hippocampal CA1 pyramidal neu-
rons in p75NTR-/- mice - (A, A’, A”) Exemplified morphology of hippocam-
pal CA1 pyramidal neurons of p75NTR-/-, 4 w infected and 8w infected, scale bar
is 100µm (B, B’) Dendritic complexity of hippocampal CA1 pyramidal neurons
(apical and basal tree), p75NTR-/- control vs p75NTR-/- 4w infected with T. gondii
(C, C’) Dendritic complexity of hippocampal CA1 pyramidal neurons (apical and
basal tree), p75NTR-/- control vs p75NTR-/- 8w infected with T. gondii (D, D’) To-
tal complexity of hippocampal CA1 pyramidal neurons apical and basal dendrites.
p75NTR-/- control vs p75NTR-/- 4w vs p75NTR-/- 8w infected with T. gondii. Data
presented as mean ± SEM. p*<0.05. The n represents the number of cells analyzed,
at least 3 animals per condition were used.
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3.1.2 p75NTR-/- mice show no difference in dendritic
architecture compared to wild type controls
Genetically deleting the exon IV in the p75NTR gene has been shown to increase the
dendritic complexity of the proximal apical dendrites in hippocampal CA1 neurons
compared to wild type controls in in vitro experiments (Zagrebelsky et al., 2005).
Figure 3.3 shows how genetically deleting the exon IV in the p75NTR gene in
B6 wt mice effects dendritic architecture of hippocampal pyramidal CA1 neurons.
Figure 3.3 A is a fluorescence micrograph of an under the Thy1 promoter eGFP
expressing hippocampal CA1 neuron of a B6 wt mouse. Figure 3.3 B and B’ show
reproductions ("tracings") CA1 neurons of B6 wt and B6-p75NTR-/- mice.
Figure 3.3 C and C’ show the results of the Sholl analysis (c.f. section 2.5.1) for
apical and basal CA1 neurons of B6 wt versus B6-p75NTR-/- mice. Both genotypes
show a similar distribution of dendritic complexity relative to the distance from the
cell body.
Figure 3.3 D shows the total complexity for apical and basal CA1 neurons of B6
wt versus B6-p75NTR-/- mice. The total number of intersections in basal and apical
dendrites of the wt and the p75NTR KO do not differ significantly. Descriptive
statistics for fig. 3.3 are listed in table 3.3.
Table 3.3: Descriptive statistics for total complexity of CA1 dendrites in fig. 3.3
Genotype CNS area T. gondii Mean±SEM
B6 WT CA1 apical - 152.9±10.49 dendritic intersections
B6-p75NTR-/- CA1 apical - 158.6±15.98 dendritic intersections
B6 WT CA1 basal - 125.2±6.895 dendritic intersections
B6-p75NTR-/- CA1 basal - 133.2±7.468 dendritic intersections
3.1.3 Dendritic spine density is altered in T. gondii infected
mice
Parlog et al ., have shown that upon T. gondii infection the dendritic architecture of
pyramidal neurons is altered (2014). Dendritic spine densities in cortex LII/III have
shown to be significantly reduced in T. gondii infected B6 wt mice. Following results
will provide insight into the effect of chronic T. gondii infection on hippocampal
CA1 neurons and cortical pyramidal LV/VI neurons in B6 controls and B6-p75NTR
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Figure 3.3: Influence of genetically deleting exon VI from the p75NTR gene in B6 mice
on dendritic complexity of hippocampal CA1 pyramidal neurons - (A)
Example of a hippocampal CA1 neuron (Thy1-eGFP), scale bar is 100µm (B, B’)
Exemplified morphology of hippocampal CA1 pyramidal neurons of B6 control and
B6-p75NTR-/- control conditions, scale bar is 100µm (C, C’) Dendritic complexity of
hippocampal CA1 pyramidal neurons (apical and basal tree) (D) Total complexity
of hippocampal CA1 pyramidal neurons apical and basal dendrites. Data presented
as mean ± SEM. * = p < 0.05, student’s t-test. The n represents the number of
cells analyzed, at least 3 animals per condition were used.
ko mice.
Figure 3.4 shows how chronic T. gondii infection effects apical dendritic spine
densities of hippocampal pyramidal CA1 neurons in B6 wt and B6-p75NTR ko mice.
Figure 3.4 A shows representative confocal microscopic images of apical CA1 neuron
dendrites in control, 4w T. gondii infected and 8w T. gondii infected B6 wt mice.
Neurons are visualized by eGFP, which is expressed under the Thy1 promoter (c.f.
section 2.5.2). Figure 3.4 B shows representative confocal microscopic images of
apical CA1 neuron dendrites in control, 4w T. gondii infected and 8w T. gondii
infected B6-p75NTR ko mice. Neurons are visualized by eGFP, which is expressed
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under the Thy1 promoter (c.f. section 2.5.2). Figure 3.4 C shows that 4w T.
gondii infected B6 wt mice have significantly less dendritic spines in CA1 apical
neuron than the control B6 wt mice. Also, 8w T. gondii infected B6 wt mice have
significantly less dendritic spines in CA1 apical neuron than the control B6 wt mice.
No significant difference in dendritic spine density between 4w T. gondii infected
versus 8w T. gondii infected B6 wt mice can be observed. Figure 3.4 D shows
that 4w T. gondii infected B6-p75NTR ko mice do not show significant differences
in dendritic spine density in CA1 apical neurons than in the control B6-p75NTR ko
mice, but 8w T. gondii infected B6-p75NTR ko mice have significantly less dendritic
spines in CA1 apical neuron than the control B6-p75NTR ko mice. Also, significant
differences in dendritic spine density between 4w T. gondii infected versus 8w
T. gondii infected B6-p75NTR ko mice can be observed. Descriptive statistics for
fig. 3.4 are listed in table 3.4.
Table 3.4: Descriptive statistics for dendritic spine densities of apical CA1 dendrites in B6 wt
and B6-p75NTR ko mice ( fig. 3.4)
Genotype CNS area T. gondii Mean±SEM
B6 WT CA1 apical - 2.221±0.2027 spines per µm
B6 WT CA1 apical 4w 1.9±0.1287 spines per µm
B6 WT CA1 apical 8w 1.724±0.1304 spines per µm
B6-p75NTR-/- CA1 apical - 2.324±0.2226 spines per µm
B6-p75NTR-/- CA1 apical 4w 2.15±0.11066 spines per µm
B6-p75NTR-/- CA1 apical 8w 1.664±0.2624 spines per µm
Figure 3.5 shows how chronic T. gondii infection effects basal dendritic spine
densities of hippocampal pyramidal CA1 neurons in B6 wt and B6-p75NTR ko mice.
Figure 3.5 A shows representative confocal microscopic images of basal CA1 neuron
dendrites in control, 4w T. gondii infected and 8w T. gondii infected B6 wt mice.
Neurons are visualized by eGFP, which is expressed under the Thy1 promoter (c.f.
section 2.5.2). Figure 3.5 B shows representative confocal microscopic images of
basal CA1 neuron dendrites in control, 4w T. gondii infected and 8w T. gondii
infected B6-p75NTR ko mice. Neurons are visualized by eGFP, which is expressed
under the Thy1 promoter (c.f. section 2.5.2). Figure 3.5 C shows that 4w T.
gondii infected B6 wt mice have significantly less dendritic spines in CA1 basal
neuron than the control B6 wt mice. Also, 8w T. gondii infected B6 wt mice have
significantly less dendritic spines in CA1 apical neuron than the control B6 wt mice.
No significant difference in dendritic spine density between 4w T. gondii infected
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Figure 3.4: Dendritic spine density in apical dendrites of hippocampal CA1 neurons
in B6 wt and p75NTR-/- mice 4w and 8w chronically infected with Toxo-
plasma gondii (A, B) Representative confocal microscopic images of apical den-
drites of pyramidal CA1 neurons in B6 wt and B5-p75NTR-/- mice; control, 4w and
8w infected with T. gondii. Scale bar is 10µm C, D Evaluation of dendritic spine
density of apical dendrites of pyramidal CA1 neurons in B6 wt and B6-p75NTR-/-
mice; control, 4w and 8w infected with T. gondii. Data presented as mean ± SEM,
p****<0.0001; p***<0.001; p**<0.01; p*<0.05
versus 8w T. gondii infected B6 wt mice can be observed. Figure 3.5 D shows
that 4w T. gondii infected B6-p75NTR ko mice do not show significant differences
in dendritic spine density in CA1 apical neurons than in the control B6-p75NTR ko
mice, but 8w T. gondii infected B6-p75NTR ko mice have significantly less dendritic
spines in CA1 apical neuron than the control B6-p75NTR ko mice. Also, significant
differences in dendritic spine density between 4w T. gondii infected versus 8w
T. gondii infected B6-p75NTR ko mice can be observed. Descriptive statistics for
fig. 3.5 are listed in table 3.5.
Figure 3.6 shows how chronic T. gondii infection effects apical dendritic spine
densities of pyramidal cortex LV/VI neurons in B6 wt and B6-p75NTR ko mice.
Figure 3.6 A shows representative confocal microscopic images of cortex LV/VI
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Figure 3.5: Dendritic spine density in basal dendrites of hippocampal CA1 neurons
in B6 wt and p75NTR-/- mice 4w and 8w chronically infected with Tox-
oplasma gondii (A, B) Representative confocal microscopic images of basal den-
drites of pyramidal CA1 neurons in B6 wt and B5-p75NTR-/- mice; control, 4w and
8w infected with T. gondii. Scale bar is 10µm C, D Evaluation of dendritic spine
density of basal dendrites of pyramidal CA1 neurons in B6 wt and B6-p75NTR-/-
mice; control, 4w and 8w infected with T. gondii. Data presented as mean ± SEM,
p****<0.0001; p***<0.001; p**<0.01; p*<0.05
neuron dendrites in control, 4w T. gondii infected and 8w T. gondii infected B6 wt
mice. Neurons are visualized by eGFP, which is expressed under the Thy1 promoter
(c.f. section 2.5.2). Figure 3.6 B shows representative confocal microscopic images
of cortex LV/VI neuron dendrites in control, 4w T. gondii infected and 8w T.
gondii infected B6-p75NTR ko mice. Neurons are visualized by eGFP, which is
expressed under the Thy1 promoter (c.f. section 2.5.2). Figure 3.6 C shows that
4w T. gondii infected B6 wt mice have significantly less dendritic spines in cortex
LV/VI neurons than the control B6 wt mice. Also, 8w T. gondii infected B6 wt
mice have significantly less dendritic spines in CA1 apical neuron than the control
B6 wt mice. Additionally significant difference in dendritic spine density between
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Table 3.5: Descriptive statistics for dendritic spine densities of basal CA1 dendrites in B6 wt
and B6-p75NTR ko mice ( fig. 3.5)
Genotype CNS area T. gondii Mean±SEM
B6 WT CA1 basal - 2.063±0.139 spines per µm
B6 WT CA1 basal 4w 1.931±0.159 spines per µm
B6 WT CA1 basal 8w 1.608±0.1571 spines per µm
B6-p75NTR-/- CA1 basal - 2.283±0.1398 spines per µm
B6-p75NTR-/- CA1 basal 4w 2.075±0.1289 spines per µm
B6-p75NTR-/- CA1 basal 8w 1.379±0.1158 spines per µm
4w T. gondii infected versus 8w T. gondii infected B6 wt mice can be observed.
Figure 3.6 D shows that 4w T. gondii infected B6-p75NTR ko mice have significantly
less dendritic spines in cortex LV/VI neurons than the control B6-p75NTR ko mice.
Also, 8w T. gondii infected B6-p75NTR ko mice have significantly less dendritic
spines in cortical apical neurons than the control B6-p75NTR ko mice. Additionally
significant difference in dendritic spine density between 4w T. gondii infected versus
8w T. gondii infected B6-p75NTR ko mice can be observed. Descriptive statistics
for fig. 3.6 are listed in table 3.6.
Table 3.6: Descriptive statistics for dendritic spine densities of apical cortex LV/VI dendrites in
B6 wt and B6-p75NTR ko mice ( fig. 3.6)
Genotype CNS area T. gondii Mean±SEM
B6 WT Ctx LV/VI apical - 1.358±0.05634 spines per µm
B6 WT Ctx LV/VI apical 4w 0.8851±0.02291 spines per µm
B6 WT Ctx LV/VI apical 8w 0.6305±0.03308 spines per µm
B6-p75NTR-/- Ctx LV/VI apical - 1.6±0.07363 spines per µm
B6-p75NTR-/- Ctx LV/VI apical 4w 1.198±0.08685 spines per µm
B6-p75NTR-/- Ctx LV/VI apical 8w 0.5258 ±0.05506 spines per µm
Figure 3.7 shows how chronic T. gondii infection effects basal dendritic spine
densities of pyramidal cortex LV/VI neurons in B6 wt and B6-p75NTR ko mice.
Figure 3.7 A shows representative confocal microscopic images of cortex LV/VI
neuron dendrites in control, 4w T. gondii and 8w T. gondii B6 wt mice. Neu-
rons are visualized by eGFP, which is expressed under the Thy1 promoter (c.f.
section 2.5.2). Figure 3.7 B shows representative confocal microscopic images of
cortex LV/VI neuron dendrites in control, 4w T. gondii and 8w T. gondii B6-
p75NTR ko mice. Neurons are visualized by eGFP, which is expressed under the
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Figure 3.6: Dendritic spine density in apical dendrites of pyramidal LV/VI neurons of
the cortex in B6 wt and p75NTR-/- mice 4w and 8w chronically infected
with Toxoplasma gondii (A, B) Representative confocal microscopic images of
apical dendrites of cortex LV/VI neurons in B6 wt and B5-p75NTR-/- mice; control,
4w and 8w infected with T. gondii. Scale bar is 10µm C, D Evaluation of dendritic
spine density of apical dendrites of pyramidal LV/VI neurons of the cortex in B6 wt
and B6-p75NTR-/- mice; control, 4w and 8w infected with T. gondii. Data presented
as mean ± SEM, p****<0.0001; p***<0.001; p**<0.01; p*<0.05
Thy1 promoter (c.f. section 2.5.2). Figure 3.7 C shows that 4w T. gondii infected
B6 wt mice have significantly less dendritic spines in cortex LV/VI neurons than
the control B6 wt mice. Also, 8w T. gondii infected B6 wt mice have significantly
less dendritic spines in CA1 apical neuron than the control B6 wt mice. No sig-
nificant difference in dendritic spine density between 4w T. gondii infected versus
8w T. gondii infected B6 wt mice can be observed. Figure 3.7 D shows that 4w
T. gondii infected B6-p75NTR ko mice do not have significantly altered dendritic
spine numbers in cortical LV/VI neurons than the control B6-p75NTR ko mice. The
8w T. gondii infected B6-p75NTR ko mice have significantly less dendritic spines
in cortical LV/VI neurons than the control B6-p75NTR ko mice. Additionally sig-
nificant difference in dendritic spine density between 4w T. gondii infected versus
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8w T. gondii infected B6-p75NTR ko mice can be observed. Descriptive statistics
for fig. 3.7 are listed in table 3.7.
Figure 3.7: Dendritic spine density in basal dendrites of pyramidal LV/VI neurons of
the cortex in B6 wt and p75NTR-/- mice 4w and 8w chronically infected
with Toxoplasma gondii (A, B) Representative confocal microscopic images of
basal dendrites of cortex LV/VI neurons in B6 wt and B5-p75NTR-/- mice; control,
4w and 8w infected with T. gondii. Scale bar is 10µm C, D Evaluation of dendritic
spine density of basal dendrites of pyramidal LV/VI neurons of the cortex in B6 wt
and B6-p75NTR-/- mice; control, 4w and 8w infected with T. gondii. Data presented
as mean ± SEM, p****<0.0001; p***<0.001; p**<0.01; p*<0.05
3.1.4 p75NTR-/- mice show increased spine density
Genetically deleting the Exon IV in the p75NTR gene has been shown to increase
spine density compared to wild type controls in in vitro experiments (Zagrebelsky
et al., 2005).
Figure 3.8 shows how genetically deleting the exon IV in the p75NTR gene in B6
wt mice effects the dendritic spine density of hippocampal pyramidal CA1 neurons.
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Table 3.7: Descriptive statistics for dendritic spine densities of basal cortex LV/VI dendrites in
B6 wt and B6-p75NTR ko mice ( fig. 3.7)
Genotype CNS area T. gondii Mean±SEM
B6 WT Ctx LV/VI basal - 1.358±0.05634 spines per µm
B6 WT Ctx LV/VI basal 4w 0.8851±0.02291 spines per µm
B6 WT Ctx LV/VI basal 8w 0.6305±0.03308 spines per µm
B6-p75NTR-/- Ctx LV/VI basal - 1.6±0.07363 spines per µm
B6-p75NTR-/- Ctx LV/VI basal 4w 1.198±0.08685 spines per µm
B6-p75NTR-/- Ctx LV/VI basal 8w 0.5258 ±0.05506 spines per µm
Figure 3.8 A shows representative confocal microscopic images of apical dendrites
of hippocampal CA1 neurons pf B6 wt and B6-p75NTR ko mice (c.f. section 2.5.2).
Figure 3.8 A’ shows that there is no significant difference in spine density between
the B6 wt and the B6-p75NTR ko mice in apical dendrites of hippocampal CA1
neurons. Figure 3.8 B shows representative confocal microscopic images of basal
dendrites of hippocampal CA1 neurons pf B6 wt and B6-p75NTR ko mice. Figure 3.8
B’ shows that there are significantly less spines on basal CA1 dendrites of B6 wt
than of B6-p75NTR ko mice. Descriptive statistics of fig. 3.8 are listed in table 3.8.
Table 3.8: Descriptive statistics for dendritic spine densities of apical and basal CA1 dendrites
in B6 wt and B6-p75NTR ko mice ( fig. 3.8)
Genotype CNS area T. gondii Mean±SEM
B6 WT CA1 apical - 2.221±0.006112 spines per µm
B6-p75NTR-/- CA1 apical - 2.324±0.09957 spines per µm
B6 WT CA1 basal - 2.063±0.04633 spines per µm
B6-p75NTR-/- CA1 basal - 2.283±0.06251 spines per µm
Figure 3.9 shows how genetically deleting the exon IV in the p75NTR gene in B6
wt mice effects the dendritic spine density of cortical LV/VI pyramidal neurons.
Figure 3.9 A shows representative confocal microscopic images of apical dendrites
of cortical LV/VI pyramidal neurons pf B6 wt and B6-p75NTR ko mice (c.f. sec-
tion 2.5.2). Figure 3.9 A’ shows that there is significantly higher spine spine density
in the B6-p75NTR ko than in the B6 wt mice in apical dendrites of cortical LV/VI
pyramidal neurons. Figure 3.9 B shows representative confocal microscopic images
of basal dendrites of cortical LV/VI pyramidal neurons pf B6 wt and B6-p75NTR ko
mice. Figure 3.9 B’ shows that there is no significant difference in spine density on
basal cortex LV/VI dendrites between B6 wt and B6-p75NTR ko mice. Descriptive
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Figure 3.8: Spine density in apical and basal dendrites of hippocampal CA1 neurons
in B6 wild type and p75NTR-/- mice – (A, A’, B, B’) Representative confocal
microscopic images and evaluation of spine density from CA1 pyramidal neurons.
Scale bar is 10 µm. Data presented as mean ± SEM, p*<0.05.
statistics of fig. 3.9 are listed in table 3.9.
Table 3.9: Descriptive statistics for dendritic spine densities of apical and basal cortex LV/VI
dendrites in B6 wt and B6-p75NTR ko mice ( fig. 3.9)
Genotype CNS area T. gondii Mean±SEM
B6 WT Ctx LV/VI apical - 1.358±0.05634 spines per µm
B6-p75NTR-/- Ctx LV/VI apical - 1.6±0.07363 spines per µm
B6 WT Ctx LV/VI basal - 1.342±0.07196 spines per µm
B6-p75NTR-/- Ctx LV/VI basal - 1.342±0.07196 spines per µm
3.1.5 The number of dendritic spines in BALB/c mice are
mostly unchanged upon T. gondii infection
Strong challenge to the immune system is usually accompanied by quantifiable
weight loss in mice. Silva et al. showed before that chronic toxoplasmosis takes a
greater toll on B6 mice than on BALB/c mice by inflicting stronger neuroinflam-
mation (2010). Figure 3.10 shows significant loss in weight for B6 mice (wt and
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Figure 3.9: Spine density in apical and basal dendrites of cortical layer V/VI pyra-
midal neurons in B6 wild type and p75NTR-/- mice – (A, A’, B, B’) Rep-
resentative confocal microscopic images and evaluation of spine density from cortex
LV/VI neurons. Scale bar is 10 µm. Data presented as mean ± SEM, p*<0.05.
p75NTR ko). BALB/c mice did not significantly lose weight. Descriptive statistics
for fig. 3.10 are listed in table 3.10.
In this context it was of interest whether dendritic morphology in BALB/c mice
is also less affected by T. gondii infection than B6 wt mice. BALB/c neurons have
been vizualized with a diolistic approach.
Figure 3.11 shows the effect of chronic T. gondii infection on dendritic spine
density of apical and basal dendrites in hippocampal CA1 neurons. Figure 3.11
A and B show representative confocal microscopic images of apical and basal CA1
neuron dendrites control and 8w T. gondii infected BALB/c wt mice. Figure 3.11
A’ shows that there is no significant difference in dendritic spine density of CA1
apical neurons in 8w T. gondii infected BALB/c wt mice compared to the BALB/c
wt controls. Figure 3.11 B’ shows a significant decrease in dendritic spines of CA1
basal neurons in 8w T. gondii BALB/c wt mice compared to the BALB/c wt
controls. Descriptive statistics for fig. 3.11 are listed in table 3.11.
Figure 3.12 shows the effect of chronic T. gondii infection on dendritic spine
density of apical and basal dendrites in cortical LV/VI neurons. Figure 3.12 A
and B show representative confocal microscopic images of apical and basal cortex
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Figure 3.10: Bodyweight upon T. gondii infection in B6 and BALB/c mice four and
eight weeks post infection - Bodyweight at ∼ 17w of age of control mice, 4w
incubated and 8w incubated B6 (wild type and p75NTR-/-) and BALB/c mice.
Data presented as mean ± SEM. *** = p < 0.001. One-way ANOVA, Fisher’s
LSD test
LV/VI neuron dendrites control and 8w T. gondii infected BALB/c wt mice. Fig-
ure 3.12 A’ and B’ show that there is no significant difference in dendritic spine
density of basal and apical dendrites in cortical LV/VI pyramidal neurons in 8w T.
gondii infected BALB/c wt mice compared to the BALB/c wt controls. Descriptive
statistics for fig. 3.12 are listed in table 3.12.
3.2 Microglial activation upon T. gondii infection
Immunological response to T. gondii infection has been in the focus of research
for many decades. While the characteristics of an infection on monocyte recruit-
ment and monocyte marker distribution are described well, the underlying signaling
mechanisms are not fully understood yet. Therefore, it was of a major interest do
study microglial reaction to T. gondii infection in p75NTR-/- mice.
This work contributes to existing knowledge by adding novel morphological in-
formation. Additionally the microglia concentration within the brain was analyzed
by determining the number of Iba1 positive (Iba1+) cells in the hippocampus as
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Table 3.10: Descriptive statistics for bodyweight upon T. gondii infection B6 wt, B6-p75NTR ko
and BALB/c wt mice ( fig. 3.10).
Genotype T. gondii Mean±SEM
B6 WT - 22.87 g ± 3.12 g
B6 WT 4w 17.07 g ±3.243 g
B6 WT 8w 16.37 g ±1.540 g
B6-p75NTR-/- - 22.30 g ±1.933 g
B6-p75NTR-/- 4w 18.01 g ± 2.547 g
B6-p75NTR-/- 8w 16.13 g ±1.717 g
BALB/c - 25.16 g ±1.516 g
BALB/c 4w 23.50 g ± 0.2646 g
BALB/c 8w 23.42 g ± 0.908 g
Table 3.11: Descriptive statistics for dendritic spine densities of apical cortex LV/VI dendrites
in B6 wt and B6-p75NTR ko mice ( fig. 3.11)
Genotype CNS area T. gondii Mean±SEM
BALB/c CA1 apical - 2.233±0.08198 spines per µm
BALB/c CA1 apical w 1.908±0.1226 spines per µm
BALB/c CA1 basal - 2.162±0.02343 spines per µm
BALB/c CA1 basal 8w 1.805±0.071 spines per µm
Table 3.12: Descriptive statistics for dendritic spine densities of apical cortex LV/VI dendrites
in B6 wt and B6-p75NTR ko mice ( fig. 3.12)
Genotype CNS area T. gondii Mean±SEM
BALB/c Ctx apical - 1.267±0.08399 spines per µm
BALB/c Ctx apical w 1.262±0.2140 spines per µm
BALB/c Ctx basal - 1.289±0.08656 spines per µm
BALB/c Ctx basal 8w 1.205±0.03976 spines per µm
well as in the cortex of in PFA fixed brains, which were deep frozen in 30µm thick
transversal sections and immunolabled with an Iba1 antibody. Iba1+ cells were
counted in a defined region of interest (ROI) and compared to controls. Results are
shown for B6 mice (WT and p75NTR-/-) and BALB/c mice. They were infected for
4 and 8 weeks.
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Figure 3.11: Dendritic spine density in apical and basal dendrites of hippocampal
CA1 neurons in control BALB/c wt and 8w chronically infected with
Toxoplasma gondii (A, B) Representative confocal microscopic images of apical
and basal dendrites of pyramidal CA1 neurons in control BALB/c wt and 8w T.
gondii infected BALB/c wt mice. Scale bar is 10µmA’, B’ Evaluation of dendritic
spine density of apical and basal dendrites of pyramidal CA1 neurons in control
BALB/c wt mice and 8w T. gondii infected BALB/c wt mice. Data presented as
mean ± SEM, p****<0.0001; p***<0.001; p**<0.01; p*<0.05
3.2.1 Morphological changes in microglia upon T. gondii
infection in B6 wt and B6-p75NTR ko mice
Microglia cells continuously survey the CNS in a ramified morphology and, in re-
sponse to injury, disease and most other CNS insults, undergo progressive morpho-
logical changes resulting in an amoeboid morphology.
Figure 3.13 shows representative confocal microscopic images of the hippocampal
stratum pyramidale in a non-infected control B6 wt mouse. Pyramidal CA1 neurons
are labeled green (Thy1 -eGFP) while microglia and marcophages are labled red
(Iba1+ cells). The upper left panel shows cell somata of the CA1 neurons are
lined up in an ordered band and their primary apical neurons extend visibly from
this cell band. The lower left panel shows several primary apical dendrites from
CA1 neurons within the stratum radiatum. The upper middle panel shows the
distribution of Iba1+ cells in the stratum pyramidale and the stratum radiatum.
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Figure 3.12: Dendritic spine density in apical and basal dendrites of cortex LV/VI
neurons in control BALB/c wt and 8w chronically infected with Toxo-
plasma gondii (A, B) Representative confocal microscopic images of apical and
basal dendrites of pyramidal cortex LV/VI in control BALB/c wt and 8w T. gondii
infected BALB/c wt mice. Scale bar is 10µm A’, B’ Evaluation of dendritic spine
density of apical and basal dendrites of cortex LV/VI neurons in control BALB/c
wt mice and 8w T. gondii infected BALB/c wt mice. Data presented as mean ±
SEM, p****<0.0001; p***<0.001; p**<0.01; p*<0.05
The lower middle panel shows a Iba1+ cell. A small cell body and numerous long
processes stretch from the soma in every direction. The right panels show a merge
of the former.
Figure 3.14 shows representative confocal microscopic images of the hippocampal
stratum pyramidale in a 8w T. gondii infected B6 wt mouse. Pyramidal CA1
neurons are labeled green (Thy1 -eGFP) while microglia and marcophages are labled
red (Iba1+ cells). The upper left panel shows cell somata of the CA1 neurons are
lined up in an ordered band and their primary apical neurons extend visibly from
this cell band. The lower left panel shows several primary apical dendrites from
CA1 neurons within the stratum radiatum. The upper middle panel shows the
distribution of Iba1+ cells in the stratum pyramidale and the stratum radiatum.
The lower middle panel shows Iba1 staining in higher magnification. No single cells
can be described in their morphology. The right panels show a merge of the former.
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Figure 3.13: Maximum intensity projection of Thy1 -eGFP labeled neurons and staining of mi-
croglia/macrophages in the stratum pyramidale of the CA1 area with primary
antibodies against ionized calcium-binding adapter molecule 1 (Iba1) respectively
in control animals not infected with T. gondii, scale bar in the large frame is 50µm,
smaller detail 25µm.
This overlay shows a association of Iba1+ cells and CA1 neurons. This is observed
in further detail in fig. 3.16.
Figure 3.16 shows representative confocal microscopic images of the hippocampal
stratum pyramidale in control and 8w T. gondii infected B6 wt mice. Pyramidal
CA1 neurons are labeled green (Thy1 -eGFP) while microglia and marcophages are
labled red (Iba1+ cells). Figure 3.16 A shows a Iba1+ cell in red and CA1 neurons
in green (Thy1 -eGFP) of a control B6 wt mouse. Figure 3.16 B shows Iba1+
staining of a blood vessel in the hippocampus of a 8w T. gondii infected B6 wt
mouse. The blood vessel is completely covered. Figure 3.16 B’ and B” show a close
association of Iba1 staining with CA1 neurons in the hippocampus of T. gondii
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Figure 3.14: Maximum intensity projection of Thy1 -eGFP labeled neurons and staining of mi-
croglia/macrophages in the stratum pyramidale of the CA1 area with primary
antibodies against ionized calcium-binding adapter molecule 1 (Iba1) respectively
in T. gondii infected B6 mice, scale bar in upper frame is 50µm, in detail frame it
is 25µm.
infected B6 wt mice. Pyramidal cell somata are coated by Iba1 as well as primary
apical dendrites.
Figure 3.15 shows that a similar picture as with the Iba1 staining can be observed
with a F4/80 staining in T. gondii infected B6 wt mice.
3.2.1.1 Morphological changes in microglia upon T. gondii infection in
BALB/c wt mice
Figure 3.17 shows representative confocal microscopic images of the hippocampal
stratum pyramidale in a 8w T. gondii infected BALB/c wt mouse. Microglia and
marcophages are labled red (Iba1+ cells). The left panel shows an overview about
microglial distribution in the hippocampal CA1 neurons. The right panel shows a
microglia cell in detail. A big cell body is covered by numerous spiky processes.
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Figure 3.15: Maximum intensity projection of Thy1 -eGFP labeled neurons and staining of mi-
croglia/macrophages in the stratum pyramidale of the CA1 area with primary
antibodies against ionized calcium-binding adapter molecule 1 (Iba1) and EGF-
like module-containing mucin-like hormone receptor-like 1 (F4/80) respectively in
T. gondii infected B6 mice, scale bar is 50µm.
3.2.2 The density of microglial cells increases upon T. gondii
infection
T. gondii infection is widely known to induce microglia activation and monocyte
recruitment (Dunay and Sibley, 2010). Most publications rely on fluorescence-
activated cell sorting (FACS). To gain further morphological insight (cf. sec-
tion 3.2.1) the brains of T. gondii infected mice were immunohistochemically stained
with an Iba1 antibody. After receiving images via fluorescence microscopy I man-
ually counted the Iba+ cells.
Figure 3.18 shows how chronic T. gondii infection effects microglia/macrophage
numbers within the stratum pyramidale of the hippocampus in B6 wt and B6-
p75NTR ko mice. Figure 3.18 A indicates the distribution of Iba1+ cells within
the hippocampal stratum pyramidale in B6 wt mice, control, 4w and 8w infected
with T. gondii. Figure 3.18 A’ shows that the total number of Iba1+ cells in
the stratum pyramidale is significantly increased in T. gondii infected B6 wt mice
compared to the controls. There is no statistical difference between 4w and 8w T.
gondii infected mice. Figure 3.18 B indicates the distribution of Iba1+ cells within
the hippocampal stratum pyramidale in B6-p75NTR ko mice, control, 4w and 8w
infected with T. gondii. Figure 3.18 B’ shows that the total number of Iba1+ cells
in the stratum pyramidale is significantly increased in T. gondii infected B6 wt mice
compared to the controls. There is no statistical difference between 4w and 8w T.
gondii infected mice. Descriptive statistics for fig. 3.18 are listed in table 3.13.
Figure 3.19 shows how chronic T. gondii infection effects microglia/macrophage
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Figure 3.16: Maximum intensity projection of Thy1 -eGFP labeled neurons and stain-
ing of microglia/macrophages in the stratum pyramidale of the CA1
area with primary antibodies against ionized calcium-binding adapter
molecule 1 (Iba1) respectively in T. gondii infected B6 mice - (A)
Healthy control B6 animal. Arrowhead indicates microglia cell, scale bar is 20µm
(B) T. gondii infected B6 mouse. Arrowheads point to microglia coating blood
vessel, scale bar is 20µm (B’, B”) T. gondii infected B6 mouse. Arrowheads in-
dicate microglia coating CA1 pyramidal neuron soma coating. Asterisks indicate
CA1 pyramidal neuron apical dendrite coating, scale bar is 20µm
numbers within the cortex in B6 wt and B6-p75NTR ko mice. Figure 3.19 A indicates
the distribution of Iba1+ cells within the cortex in B6 wt mice, control, 4w and 8w
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Figure 3.17: Maximum intensity projection of staining of microglia/macrophages in the stra-
tum pyramidale of the CA1 area with primary antibodies against ionized calcium-
binding adapter molecule 1 (Iba1) respectively in T. gondii infected BALB/c mice,
scale bar in the left frame is 25µm, detail frame 10µm.
Figure 3.18: Quantification of microglia/macrophages in hippocampal stratum pyra-
midale B6 wt and B6-p75NTR ko mice infected with T. gondii for 4w
and 8w (A, B) Immunohistochemistry of stratum pyramidale CA1 area of B6
wt and B6-p75NTR ko mice infected with T. gondii for 4w and 8w. Red is Iba1,
blue is DAPI, scale bar is 100µm. White asterisk indicate Iba1+ cells (A’, B’)
Evaluation of the number of Iba1+ cells in the stratum pyramidale CA1 area of B6
and B6-p75NTR ko mice infected with T. gondii for 4w and 8w. Data presented
as mean ± SEM, p*<0.05; p****<0.0001.
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Table 3.13: Descriptive statistics for hippocampal Iba1+ cell numbers in T. gondii infected B6
wt and B6-p75NTR ko mice ( fig. 3.18).
Genotype CNS area T. gondii Mean±SEM
B6 WT stratum pyramidale - 7.36±0.2939 cells per mm3
B6 WT stratum pyramidale 4w 25.73±1.234 cells per mm3
B6 WT stratum pyramidale 8w 22.84±4.047 cells per mm3
B6-p75NTR-/- stratum pyramidale - 8.728±0.2841 cells per mm3
B6-p75NTR-/- stratum pyramidale 4w 21.94±1.68 cells per mm3
B6-p75NTR-/- stratum pyramidale 8w 17.85±1.274 cells per mm3
infected with T. gondii. Figure 3.19 A’ shows that the total number of Iba1+ cells
in the cortex is significantly increased in T. gondii infected B6 wt mice compared to
the controls. There is no statistical difference between 4w and 8w T. gondii infected
mice. Figure 3.19 B indicates the distribution of Iba1+ cells within the cortex in
B6-p75NTR ko mice, control, 4w and 8w infected with T. gondii. Figure 3.19 B’
shows that the total number of Iba1+ cells in the stratum pyramidale is significantly
increased in T. gondii infected B6 wt mice compared to the controls. There is no
statistical difference between 4w and 8w T. gondii infected mice. Descriptive
statistics for fig. 3.19 are listed in table 3.14.
Table 3.14: Descriptive statistics for hippocampal Iba1+ cell numbers in T. gondii infected B6
wt and B6-p75NTR ko mice ( fig. 3.19).
Genotype CNS area T. gondii Mean±SEM
B6 WT Cortex - 8.139±0.4066 cells per mm3
B6 WT Cortex 4w 26.57±1.594 cells per mm3
B6 WT Cortex 8w 22.84±4.047 cells per mm3
B6-p75NTR-/- Cortex - 10.57±0.3258 cells per mm3
B6-p75NTR-/- Cortex 4w 24.63±1.542 cells per mm3
B6-p75NTR-/- Cortex 8w 21.4±2.581 cells per mm3
3.2.3 p75NTR-/- mice show increased numbers of Iba1+ cells
compared to the B6 wt controls
The influence of the p75NTR on microglia cells has been studied in last two decades
(Nakajima et al., 1998; Srinivasan et al., 2004; Meeker et al., 2016) and the overall
participation of the p75NTR in injury and disease rose to general interest (Meeker
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Figure 3.19: Quantification of microglia/macrophages in the cortex of B6 wt and
B6-p75NTR ko mice infected with T. gondii for 4w and 8w (A, B)
Immunohistochemistry of cortex of B6 wt and B6-p75NTR ko mice infected with
T. gondii for 4w and 8w. Red is Iba1, blue is DAPI, scale bar is 100µm. White
asterisk indicate Iba1+ cells (A’, B’) Evaluation of the number of Iba1+ cells in
the cortex of B6 and B6-p75NTR ko mice infected with T. gondii for 4w and 8w.
Data presented as mean ± SEM, p*<0.05; p****<0.0001.
and Williams, 2014).
Figure 3.20 shows deleting the exon IV from the p75NTR gene effects microglia
numbers within the stratum pyramidale of the hippocampus and the cortex in B6
wt and B6-p75NTR ko mice. Figure 3.20 A indicates the distribution of Iba1+ cells
within the hippocampal stratum pyramidale in B6 wt mice and B6-p75NTR ko mice.
Figure 3.20 B indicates the distribution of Iba1+ cells within the cortex in B6 wt
and B6-p75NTR ko mice. Figure 3.20 C shows that the total number of Iba1+ cells
in the stratum pyramidale is significantly increased in B6-p75NTR ko mice compared
to B6 wt mice. Figure 3.20 D shows that the total number of Iba1+ cells in the
cortex is significantly increased in B6-p75NTR ko mice compared to B6 wt mice.
Descriptive statistics for fig. 3.20 are listed in table 3.15.
3.2.4 The number of Iba1+ cells increases in BALB/c mice
upon T. gondii infection
The findings of the impact of chronic T. gondii infection on microglial morphology
raised the question on the number of Iba1+ cells upon infection in BALB/c wt
mice and their relative numbers to the B6 wt strain.
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Figure 3.20: Quantification of microglia/macrophages in hippocampal stratum pyra-
midale and cortex sections of B6 wt controls and p75NTR-/- controls (A,
B) Immunohistochemistry of stratum pyramidale CA1 area and cortex area of B6
wt controls and B6-p75NTR ko controls mice. Red is Iba1, blue is DAPI, scale bar
is 100µm, asterisks indicate Iba1+ cells (C, D) The number of Iba1+ cells in the
stratum pyramidale CA1 area and cortex area of B6 and B6-p75NTR-/- mice. Data
presented as mean ± SEM, p*<0.05; p**<0.01; p***<0.001; p****<0.0001.
Figure 3.21 shows how chronic T. gondii infection effects microglia/macrophage
numbers within the stratum pyramidale of the hippocampus and the cortex in
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Table 3.15: Descriptive statistics for hippocampal and cortical Iba1+ cell numbers in B6 wt and
B6-p75NTR ko mice ( fig. 3.18).
Genotype CNS area T. gondii Mean±SEM
B6 WT stratum pyramidale - 7.36±0.2939 cells per mm3
B6 WT Cortex - 8.139±0.4066 cells per mm3
B6-p75NTR-/- stratum pyramidale - 8.728±0.2841 cells per mm3
B6-p75NTR-/- Cortex - 10.57±0.3258 cells per mm3
BALB/c wt mice. Figure 3.21 A indicates the distribution of Iba1+ cells within
the hippocampal stratum pyramidale in BALB/c wt controls (upper panel) and 8w
T. gondii infected T. gondii BALB/c wt mice (lower panel).
Table 3.16: Descriptive statistics for hippocampal Iba1+ cell numbers in T. gondii infected B6
wt and B6-p75NTR ko mice ( fig. 3.22).
Genotype CNS area T. gondii Mean±SEM
BALB/c WT stratum pyramidale - 6,476±0,5106 cells per mm3
B6 WT stratum pyramidale - 7.36±0.2939 cells per mm3
BALB/c WT Cortex - 6,900±0,3584 cells per mm3
B6 WT Cortex - 8.139±0.4066 cells per mm3
Figure 3.21 B indicates the distribution of Iba1+ cells within the cortex in
BALB/c wt controls (upper panel) and 8w T. gondii infected T. gondii BALB/c
wt mice (lower panel). Figure 3.21 A’ shows that the total number of Iba1+ cells
in the stratum pyramidale is significantly increased in T. gondii infected BALB/c
wt mice compared to the controls. Figure 3.21 B’ shows that the total number of
Iba1+ cells in the cortex is significantly increased in T. gondii infected BALB/c
wt mice compared to the controls. Descriptive statistics for fig. 3.21 are listed in
table 3.17.
Table 3.17: Descriptive statistics for hippocampal and cortical Iba1+ cell numbers in T. gondii
infected BALB/c wt mice ( fig. 3.21).
Genotype CNS area T. gondii Mean±SEM
BALB/c WT stratum pyramidale - 6,476±0,5106 cells per mm3
BALB/c WT stratum pyramidale 8w 16,84±0,9265 cells per mm3
BALB/c WT Cortex - 6,900±0,3584 cells per mm3
BALB/c WT Cortex 8w 17,94±0,9848 cells per mm3
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Figure 3.21: Quantification of microglia/macrophages in hippocampal stratum pyra-
midale and cortex sections of BALB/c wt controls 8w T. gondii infected
BALB/c wt mice (A, B) Immunohistochemistry of stratum pyramidale area and
cortex area of BALB/c wt control mice and 8w T. gondii infected BALB/c wt mice.
Red is Iba1, blue is DAPI, scale bar is 100µm, asterisks indicate Iba1+ cells (C, D)
The number of Iba1+ cells in the stratum pyramidale and cortex area of BALB/c
wt control mice and 8w T. gondii infected BALB/c wt mice. Data presented as
mean ± SEM, p*<0.05; p**<0.01; p***<0.001; p****<0.0001.
Figure 3.22 shows how microglia/macrophage numbers differ within the stratum
pyramidale of the hippocampus and the cortex in BALB/c wt mice compared to
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B6 wt mice. Figure 3.22 A indicates the distribution of Iba1+ cells within the hip-
pocampal stratum pyramidale in BALB/c wt B6 wt mice. Figure 3.22 B indicates
the distribution of Iba1+ cells within the cortex in BALB/c wt controls and B6
wt mice. Figure 3.22 A’ shows that the total number of Iba1+ cells in the stra-
tum pyramidale is not significantly different in BALB/c wt mice compared to B6
wt mice. Figure 3.22 B’ shows that the total number of Iba1+ cells in the cortex
is significantly increased BALB/c wt mice compared to B6 wt mice. Descriptive
statistics for fig. 3.22 are listed in table 3.16.
3.2.5 Iba1 immuno reactivity increases upon T. gondii
infection in B6 mice
Iba1 has also been used to analyze microglial activation. While microglia undergo
cytoskeletal rearrangements that alter their morphology (Davalos et al., 2005), mor-
phological changes may not ultimately represent active inflammatory profiles ac-
curately (section 3.2.1). Additionally to the number of Iba1+ cells I measured
fluorescence intensity.
Table 3.18: Descriptive statistics for Iba1 immuno reactivity in B6 wt and B6-p75NTR ko mice
upon T. gondii infection ( fig. 3.23).
Genotype CNS area T. gondii Mean±SEM
B6 wt Cortex - 14473±1212 ID per 0.13mm3
B6 wt Cortex 8w 194656±19571 ID per 0.13mm3
B6-p75NTR ko Cortex - 88407±3960 ID per 0.13mm3
B6-p75NTR ko Cortex 8w 311053±13896 ID per 0.13mm3
B6-p75NTR ko CA1 - 62148±3102 ID per 0.13mm3
B6-p75NTR ko CA1 8w 269276±23887 ID per 0.13mm3
B6-p75NTR ko DG - 65989±33342 ID per 0.13mm3
B6-p75NTR ko DG 8w 288935±9850 ID per 0.13mm3
Figure 3.23 shows the impact of chronic (8w) T. gondii infection on Iba1 immuno
reactivity in B6 wt and B6-p75NTR ko mice. Figure 3.23 A and A’ are representa-
tive confocal microscopic images of the cortex of B6 wt and B6-p75NTR ko mice,
which have been stained with an anti-Iba1 antibody. The increase in Iba1 immuno
reactivity is clear. Figure 3.23 B, C and D show a significant increase in Iba1 im-
muno reactivity in B6-p75NTR ko mice upon T. gondii infection in the CA1, DG
and cortex region. Figure 3.23 D’ shows there is significant increase in Iba1 immuno
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Figure 3.22: Quantification of microglia/macrophages in hippocampal stratum pyra-
midale and cortex sections of B6 wt controls and BALB/c wt controls
(A, B) Immunohistochemistry of stratum pyramidale CA1 area and cortex area of
B6 wt controls and BALB/c wt control mice. Red is Iba1, blue is DAPI, scale bar
is 100µm, asterisks indicate Iba1+ cells (C, D) The number of Iba1+ cells in the
stratum pyramidale and cortex area of B6 and BALB/c wt mice. Data presented
as mean ± SEM, p*<0.05; p**<0.01; p***<0.001; p****<0.0001.
reactivity in the cortex of 8w T. gondii infected B6 wt mice. Descriptive statistics
of fig. 3.23 are listed in table 3.18.
Figure 3.24 shows the impact of chronic (8w) T. gondii infection on Iba1 immuno
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Figure 3.23: Influence of a chronic Toxoplasma gondii infection on Iba1 immunore-
activity in B6 wild type and B6-p75NTR-/- mice - (A, A’) Exemplified in-
tensity measurements (100ms exposure) for B6 wild type and B6-p75NTR ko mice.
Control upper panels, T. gondii infected lower panels. Scale bar is 50µm. Pictures
were taken within the cortex. (B, C, D,) Integrated density of B6-p75NTR-/- mice
in hippocampal stratum pyramidale, dentate gyrus and the entorhinal cortex, con-
trol and 8w T. gondii infected. (D’) Integrated density of T. gondii infected and
control B6 wild type mice in entorhinal cortex. Data presented as mean ± SEM.
p**** < 0.0001
reactivity in B6 wt and B6-p75NTR ko mice. Figure 3.24 A and A’ are representative
confocal microscopic images of the cortex of 8w T. gondii infected B6 wt and B6-
p75NTR ko mice, which have been stained with an anti-Iba1 antibody. The difference
in Iba1 immuno reactivity is visibly higher in the B6-p75NTR ko mice. Figure 3.24
B, C and D show a significant increase in Iba1 immuno reactivity in B6-p75NTR ko
mice upon T. gondii infection in the CA1, DG and cortex region compared to the
B6 wt mice. Descriptive statistics of fig. 3.24 are listed in table 3.19.
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Figure 3.24: Influence of chronic T. gondii infection on Iba1 immunoreactivity in the
cortex of B6 wild type and B6-p75NTR ko mice - (A, A’) Exemplified
intensity measurements (100ms exposure) for control B6 wild type and control
B6-p75NTR ko mice in the cortex. Scale bar is 50µm. (B) Integrated density of
control B6 wt mice and B6-p75NTR-/- mice in entorhinal cortex. Data presented as
mean ± SEM. p**** < 0.0001
Table 3.19: Descriptive statistics for Iba1 immuno reactivity in B6 wt and B6-p75NTR ko mice
upon T. gondii infection ( fig. 3.24).
Genotype CNS area T. gondii Mean±SEM
B6 wt Cortex 8w 194656±19571 ID per 0.13mm3
B6 wt CA1 8w 183406±17616 ID per 0.13mm3
B6 wt DG 8w 239470±17309 ID per 0.13mm3
B6-p75NTR ko Cortex 8w 311053±13896 ID per 0.13mm3
B6-p75NTR ko CA1 8w 269276±23887 ID per 0.13mm3
B6-p75NTR ko DG 8w 288935±9850 ID per 0.13mm3
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3.2.6 Iba1 immuno reactivity is increased in the cortex of
B6-p75NTR ko control mice compared to B6 wt control
mice
Figure 3.25 shows the impact of the deletion of the exon IV of the p75NTR gene in B6
mice on Iba1 immuno reactivity compared to B6 wt control mice. Figure 3.25 A and
A’ are representative confocal microscopic images of the cortex of B6 wt and B6-
p75NTR ko mice, which have been stained with an anti-Iba1 antibody. Figure 3.25
B shows a significant increase in Iba1 immuno reactivity in B6-p75NTR ko mice
compared to the control B6 wt mice in the cortex region. Descriptive statistics of
fig. 3.25 are listed in table 3.20
Table 3.20: Descriptive statistics for Iba1 immuno reactivity in B6 wt and B6-p75NTR ko mice
( fig. 3.25).
Genotype CNS area T. gondii Mean±SEM
B6 wt Cortex - 14473±1212 ID per 0.13mm3
B6-p75NTR ko Cortex - 88407±3960 ID per 0.13mm3
Figure 3.25: Influence of p75NTR ko on Iba1 immunoreactivity in the cortex of B6
wild type mice - (A, A’) Exemplified intensity measurements (100ms exposure)
for control B6 wild type and control B6-p75NTR ko mice in the cortex. Scale bar
is 50µm. (B) Integrated density of control B6 wt mice and B6-p75NTR-/- mice in
entorhinal cortex. Data presented as mean ± SEM. p**** < 0.0001
3.2.7 Iba1 immuno reactivity increases upon T. gondii
infection in BALB/c mice
Figure 3.26 shows the impact of chronic (8w) T. gondii infection on Iba1 immuno
reactivity in BALB/c wt mice. Figure 3.26 A and A’ are representative confocal
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Table 3.21: Descriptive statistics for Iba1 immuno reactivity in BALB/c wt mice upon T. gondii
infection ( fig. 3.26).
Genotype CNS area T. gondii Mean±SEM
BALB/c wt Cortex - 45144±1603 ID per 0.13mm3
BALB/c wt Cortex 8w 611254±62942 ID per 0.13mm3
BALB/c wt CA1 - 36770±2290 ID per 0.13mm3
BALB/c wt CA1 8w 557094±88116 ID per 0.13mm3
BALB/c wt DG - 36338±2651 ID per 0.13mm3
BALB/c wt DG 8w 662142±73075 ID per 0.13mm3
Table 3.22: Descriptive statistics for Iba1 immuno reactivity in BALB/c wt mice upon T. gondii
infection ( fig. 3.27).
Genotype CNS area T. gondii Mean±SEM
BALB/c wt Cortex - 45144±1603 ID per 0.13mm3
B6 wt Cortex - 14473±1212 ID per 0.13mm3
microscopic images of the cortex of BALB/c wt mice, which have been stained with
an anti-Iba1 antibody. The increase in Iba1 immuno reactivity is clear in the 8w
T. gondii infected mice. Figure 3.26 B, C and D show a significant increase in Iba1
immuno reactivity in BALB/c mice upon T. gondii infection in the CA1, DG and
cortex region. Figure 3.23 Descriptive statistics of fig. 3.26 are listed in table 3.21.
Figure 3.27 shows differences in Iba1 immuno reactivity between B6 wt and
BALB/c wt mice in the cortex. Figure 3.27 A and A’ are representative confocal
microscopic images of the cortex of B6 wt and BALB/c ko mice, which have been
stained with an anti-Iba1 antibody. Figure 3.27 B shows a significant increase in
Iba1 immuno reactivity in BALB/c mice compared to the control B6 wt mice in
the cortex region. Descriptive statistics of fig. 3.27 are listed in table 3.22
Figure 3.28 shows the impact of chronic (8w) T. gondii infection on Iba1 immuno
reactivity in B6 wt and BALB/c wt mice. Figure 3.28 A and A’ are representative
confocal microscopic images of the cortex of 8w T. gondii infected B6 and BALB/c
wt mice, which have been stained with an anti-Iba1 antibody. The difference in
Iba1 immuno reactivity is visibly higher in the BALB/c wt mice. Figure 3.28 B, C
and D show a significant increase in Iba1 immuno reactivity in BALB/c wt mice
upon T. gondii infection in the CA1, DG and cortex region compared to the B6 wt
mice. Descriptive statistics of fig. 3.28 are listed in table 3.23.
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Figure 3.26: Influence of a chronic Toxoplasma gondii infection on Iba1 immunore-
activity in BALB/c wild type mice - (A, A’) Exemplified intensity mea-
surements (100ms exposure) for BALB/c wt mice. Control left panels T. gondii
infected right panel. Scale bar is 50µm. Pictures were taken within the cortex. (B,
C, D,) Integrated density of BALB/c wt mice in hippocampal stratum pyramidale,
dentate gyrus and the entorhinal cortex, control and 8w T. gondii infected. Data
presented as mean ± SEM. p**** < 0.0001
Figure 3.27: Comparison between the Iba1 immuno reactivity of B6 wt and BALB/c
wt mice in the cortex - (A, A’) Exemplified intensity measurements (100ms
exposure) for control B6 wild type and control BALB/c wt mice in the cortex.
Scale bar is 50µm. (B) Integrated density of control B6 wt mice and BALB/c wt
mice in entorhinal cortex. Data presented as mean ± SEM. p**** < 0.0001
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Figure 3.28: Influence of a chronic Toxoplasma gondii infection on Iba1 immunore-
activity in BALB/c and B6 wild type mice - (A, A’) Exemplified intensity
measurements (100ms exposure) for 8w T. gondii BALB/c and B6 wt mice. Scale
bar is 50µm. Pictures were taken within the cortex. (B, C, D,) Integrated density
of BALB/c and B6 wt mice in hippocampal stratum pyramidale, dentate gyrus and
the entorhinal cortex, control and 8w T. gondii infected. Data presented as mean
± SEM. p**** < 0.0001
Table 3.23: Descriptive statistics for Iba1 immuno reactivity in B6 wt and BALB/c wt mice
upon T. gondii infection ( fig. 3.28).
Genotype CNS area T. gondii Mean±SEM
B6 wt Cortex 8w 194656±19571 ID per 0.13mm3
B6 wt CA1 8w 183406±17616 ID per 0.13mm3
B6 wt DG 8w 239470±17309 ID per 0.13mm3
BALB/c wt Cortex 8w 611254±62942 ID per 0.13mm3
BALB/c wt CA1 8w 557094±88116 ID per 0.13mm3
BALB/c wt DG 8w 662142±73075 ID per 0.13mm3
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3.3 Neurotrophin receptor translation is effected
by T. gondii infection
As deleting the p75NTR exon IV effects neuronal architecture in the hippocampus
and the cortex (section 3.1) of T. gondii infected B6 mice differently than the wt
control, p75NTR protein levels in B6 and BALB/c (section 3.3.2) control animals
were quantified as well as in mice, which have been chronically infected with T.
gondii for 8w.
Figure 3.29 shows the effect of 8w chronic T. gondii infection on p75NTR protein
levels in the cortex of B6 wt mice. Figure 3.29 A shows representative protein bands
from Western blots. While the internal standard (GAPDH) is equally distributed
in B6 wt controls and 8w T. gondii infected B6 wt mice, p75NTR levels are reduced
in T. gondii infected B6 wt mice. Figure 3.29 B shows a significant reduction in
p75NTR protein levels in 8w T. gondii infected B6 wt mice compared to the control.
Descriptive statistic of fig. 3.29 are listed in table 3.24.
Table 3.24: Descriptive statistics for p75NTR protein level in T. gondii infected B6 wt mice
(fig. 3.29)
.
Genotype CNS area T. gondii Mean±SEM
B6 wt Cortex - normalized to 1
B6 wt Cortex 8w 0,4610±0,01614 of B6 wt control
Figure 3.29: Quantification of p75NTR in cortical brain tissue of B6 wt controls and
in 8w T. gondii infected B6 wt mice (A) Exemplified Western blots. The
antibodies used were anti-p75NTR (rabbit, polyclonal,abcam ab38335, 1:1000) and
anti-GAPDH (rabbit polyclonal, Acris AP21839PUN, 1:3000 ) (B) To control mice
normalized amount of p75NTR in cortical brain tissue of 8w T. gondii infected B6.
Data presented as mean ± SEM, p*<0.05; p**<0.01; p***<0.001; p****<0.0001.
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3.3.1 Both isoforms of TrkB are effected by chronic T.
gondii infection in B6 wt and B6-p75NTR ko mice
P75NTR exerts its functions by interacting with other receptors. Heterodimers con-
sisting of Trk receptors and p75NTR promote growth and pro-survival signaling
while increasing the affinity of major neurotrophins to the respective Trk receptor
100-fold compared to the Trk homodimer (Hempstead 1991; Bibel 1999). Impor-
tantly TrkB, activated by BDNF, promotes neuronal differentiation, growth and
survival. To gain further insight chronically Toxoplasma gondii infected B6 wt,
B6-p75NTR ko and BALB/c (section 3.3.2) wt were analyzed for the protein level
of TrkB.
Table 3.25: Descriptive statistics for TrkB protein level in T. gondii infected B6 wt and B6-
p75NTR ko mice (fig. 3.30)
.
Genotype CNS area T. gondii TrkB isoform Mean±SEM
B6 wt Cortex - FL normalized to 1
B6 wt Cortex - T1 normalized to 1
B6 wt Cortex 4w FL 0,5900±0,04922
B6 wt Cortex 4w T1 0,4151±0,03131
B6 wt Cortex 8w FL 0,3458±0,05218
B6 wt Cortex 8w T1 0,6342±0,02947
B6-p75NTR ko Cortex - FL 1,573±0,2389
B6-p75NTR ko Cortex - T1 1,186±0,1449
B6-p75NTR ko Cortex 4w FL 0,5099±0,1883
B6-p75NTR ko Cortex 4w T1 0,3404±0,01200
B6-p75NTR ko Cortex 8w FL 0,3744±0,01482
B6-p75NTR ko Cortex 8w T1 0,4783±0,04024
Figure 3.30 shows the effect of 4w and 8w chronic T. gondii infection on TrkB
protein levels (both isoforms, full length and T1) in cortical tissue of B6 wt and B6-
p75NTR ko mice. Figure 3.30 A shows representative protein bands from Western
blots. While the internal standard (Tubulin) is equally distributed, TrkB protein
levels are visibly reduced in B6 wt and B6-p75NTR ko mice upon T. gondii infection.
Figure 3.30 B shows that there is no significant difference in the truncated TrkB
isoform (T1) in B6 wt controls compared to the B6-p75NTR ko mice. Figure 3.30 C
and D show significant decrease in truncated TrkB levels upon T. gondii infection
in B6 wt and B6-p75NTR ko mice. Figure 3.30 B’ shows a significant increase in full
length TrkB in B6-p75NTR ko mice compared to the B6 wt controls. Figure 3.30 C’
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and D’ show significant decrease in full length TrkB levels upon T. gondii infection
in B6 wt and B6-p75NTR ko mice. Descriptive statistic of fig. 3.30 are listed in
table 3.25.
Table 3.26: Descriptive statistics for TrkB protein level in T. gondii infected B6 wt and B6-
p75NTR ko mice (fig. 3.31)
.
Genotype CNS area T. gondii TrkB isoform Mean±SEM
B6 wt Hippocampus - FL normalized to 1
B6 wt Hippocampus - T1 normalized to 1
B6 wt Hippocampus 4w FL 0,9329±0,2271
B6 wt Hippocampus 4w T1 0,5615±0,1218
B6 wt Hippocampus 8w FL 0,5172±0,09620
B6 wt Hippocampus 8w T1 0,3192±0,06385
B6-p75NTR ko Hippocampus - FL 0,8947±0,08983
B6-p75NTR ko Hippocampus - T1 0,9212±0,1323
B6-p75NTR ko Hippocampus 4w FL 0,8266±0,07342
B6-p75NTR ko Hippocampus 4w T1 0,6681±0,1647
B6-p75NTR ko Hippocampus 8w FL 0,5202±0,2386
B6-p75NTR ko Hippocampus 8w T1 0,4873±0,04127
Figure 3.31 shows the effect of 4w and 8w chronic T. gondii infection on TrkB
protein levels (both isoforms, full length and T1) in hippocampal tissue of B6
wt and B6-p75NTR ko mice. Figure 3.31 A shows representative protein bands
from Western blots. Differences in the single panels are observed with a trend of
reduced TrkB isoforms in T. gondii infected mice in both genotypes. Figure 3.31
B shows that there is no significant difference in the truncated TrkB isoform (T1)
in B6 wt controls compared to the B6-p75NTR ko mice. Figure 3.31 C shows a
significant decrease in truncated TrkB levels upon T. gondii infection in B6 wt
mice. Figure 3.31 D shows no significant decrease in truncated TrkB levels upon
T. gondii infection in B6-p75NTR ko mice. Figure 3.31 B’ shows no significant
increase in full length TrkB in B6-p75NTR ko mice compared to the B6 wt controls.
Figure 3.30 C’ and D’ show no significant differences in full length TrkB levels
upon T. gondii infection in B6 wt and B6-p75NTR ko mice. Descriptive statistic of
fig. 3.31 are listed in table 3.26.
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Figure 3.30: Quantification of TrkB (T1 and full length) in cortical brain tissue of
B6 wt and B6-p75NTR ko controls and in 4w and 8w T. gondii infected
mice (A) Exemplified Western blots. The antibodies used were anti-TrkB (rabbit,
polyclonal, Milipore 07-225, 1:2000) and anti-Tubulin (mouse monoclonal, Sigma-
Aldrich, ® T9026, 1:10000) (B, B’ ) To B6 control mice normalized amount of
TrkB (T1 and full length) in p75NTR-/- mice in brain tissue. (C, C’ ) To B6
control mice normalized amount of TrkB (T1 and full length) in 4w and 8w T.
gondii infected B6 mice. (D, D’ ) To B6 control mice normalized amount of TrkB
(T1 and full length) in control, 4w and 8w T. gondii infected p75NTR-/- mice.
Data presented as mean ± SEM, p*<0.05; p**<0.01; p***<0.001; p****<0.0001.
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Figure 3.31: Quantification of TrkB (T1 and full length) in hippocampal brain tissue
of B6 wt and B6-p75NTR ko controls and in 4w and 8w T. gondii in-
fected mice (A) Exemplified Western blots. The antibodies used were anti-TrkB
(rabbit, polyclonal, Milipore 07-225, 1:2000) and anti-Tubulin (mouse monoclonal,
Sigma-Aldrich, ® T9026, 1:10000) (B, B’ ) To B6 control mice normalized amount
of TrkB (T1 and full length) in p75NTR-/- mice in brain tissue. (C, C’ ) To B6
control mice normalized amount of TrkB (T1 and full length) in 4w and 8w T.
gondii infected B6 mice. (D, D’ ) To B6 control mice normalized amount of TrkB
(T1 and full length) in control, 4w and 8w T. gondii infected p75NTR-/- mice.
Data presented as mean ± SEM, p*<0.05; p**<0.01; p***<0.001; p****<0.0001.
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Table 3.27: Descriptive statistics for p75NTR protein level in T. gondii infected BALB/c wt mice
(fig. 3.32)
.
Genotype CNS area T. gondii Mean±SEM
BALB/c wt Cortex - normalized to 1
BALB/c wt Cortex 8w 0,3570±0,06751 of control
Figure 3.32: Quantification of p75NTR in cortical brain tissue of BALB/c wt controls
and in 8w T. gondii infected B6 wt mice (A, B) Exemplified Western blots.
The antibodies used were anti-p75NTR (rabbit, polyclonal,abcam ab38335, 1:1000)
and anti-GAPDH (rabbit polyclonal, Acris AP21839PUN, 1:3000 ) (A’, B’ ) To
control mice normalized amount of p75NTR in cortical brain tissue of 8w T. gondii
infected BALB/c wt mice. Data presented as mean ± SEM, p*<0.05; p**<0.01;
p***<0.001; p****<0.0001.
3.3.2 p75NTR and both isoforms of TrkB are reduced by
chronic T. gondii infection in BALB/c wt mice
To elucidate whether the effect on neurotrophin receptor levels upon T. gondii
infection is mouse strain specific BALB/c wt mice were also analyzed for their
p75NTR and TrkB levels.
Figure 3.32 shows the effect of 8w chronic T. gondii infection on p75NTR protein
levels in the cortex of BALB/c wt mice. Figure 3.32 A shows representative pro-
tein bands from Western blots. While the internal standard (GAPDH) is equally
distributed in BALB/c wt controls and 8w T. gondii infected BALB/c wt mice,
p75NTR levels are reduced in T. gondii infected BALB/c wt mice. Figure 3.29 B
shows a significant reduction in p75NTR protein levels in 8w T. gondii infected
BALB/c wt mice compared to the control. Descriptive statistic of fig. 3.32 are
listed in table 3.27.
Figure 3.33 shows the effect of 4w and 8w chronic T. gondii infection on TrkB
protein levels (both isoforms, full length and T1) in hippocampal and cortical tissue
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Table 3.28: Descriptive statistics for TrkB protein level in T. gondii infected B6 wt and B6-
p75NTR ko mice (fig. 3.33)
.
Genotype CNS area T. gondii TrkB isoform Mean±SEM
BALB/c wt Hippocampus - FL normalized to 1
BALB/c wt Hippocampus - T1 normalized to 1
BALB/c wt Hippocampus 8w FL 0,8361±0,08320
BALB/c wt Hippocampus 8w T1 1,048±0,1798
BALB/c wt Cortex - FL normalized to 1
BALB/c wt Cortex - T1 normalized to 1
BALB/c wt Cortex 8w FL 0,5413±0,06206
BALB/c wt Cortex 8w T1 0,4783±0,04024
of BALB/c wt mice. Figure 3.33 A shows representative protein bands from West-
ern blots from hippocampal tissue. Differences in the single panels are observed
with a trend of reduced full length TrkB in 8w T. gondii infected BALB/c wt mice.
Figure 3.33 B and B’ show that there is no significant difference in both TrkB iso-
forms in BALB/c wt controls compared to the 8w T. gondii infected BALB/c wt
mice in hippocampal tissue. Figure 3.33 C shows representative protein bands from
Western blots from cortical tissue. Differences in the single panels are observed with
a trend of reduced full length TrkB and truncated TrkB in 8w T. gondii infected
BALB/c wt mice. Figure 3.33 D and D’ show significant decrease in both TrkB
isoform levels upon T. gondii infection in BALB/c wt mice. Descriptive statistic
of fig. 3.33 are listed in table 3.28.
3.3.2.1 Transgenic mice overexpress TrkB isoforms
The results showing that T. gondii infection decreases TrkB in B6 an BALB/c
mice promted to follow this information up by infecting mice overexpressing TrkB
to elucidate the effect neuronal architecture and microglial activation. To validate
existing transgenic mouse lines indeed overexpress TrkB isoforms, Western blot
analyzes was performed.
Figure 3.34 shows the effect on TrkB protein levels in TrkB.T1+ and TrkB.TK+
compared to B6 wt controls. Figure 3.34 A shows representative protein bands
from Western blots. While the internal standard (Tubulin) is equally distributed in
the B6 wt control and TrkB.T1+ mouse, the truncated TrkB isoform (TrkB.T1) is
clearly increased in the TrkB.T1+ mouse while the full length isoform is not visibly
altered. Figure 3.34 A’ shows a significant increase in truncated TrkB (TrkB.T1)
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Figure 3.33: Quantification of TrkB (T1 and full length) in cortical and hippocam-
pal brain tissue of BALB/c wt controls and in 8w T. gondii infected
BALB/c wt mice (A, C) Exemplified Western blots. The antibodies used were
anti-TrkB (rabbit, polyclonal, Milipore 07-225, 1:2000) and anti-Tubulin (mouse
monoclonal, Sigma-Aldrich, ® T9026, 1:10000) (B, B’, D, D’ ) To BALB/c wt
control mice normalized amount of TrkB (T1 and full length) in 8w T. gondii in-
fected BALB/c wt mice in brain tissue. Data presented as mean ± SEM, p*<0.05;
p**<0.01; p***<0.001; p****<0.0001.
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in the TrkB.T1+ mouse compared to the B6 wt control. Figure 3.34 A” shows no
significant differences in full length TrkB between the TrkB.T1+ mouse and the
B6 wt control. Figure 3.34 B shows representative protein bands from Western
blots. While the internal standard (Tubulin) is equally distributed in the B6 wt
control and TrkB.TK+ mouse, the full length TrkB isoform shows a bigger band
in the TrkB.TK+ mouse compared to the B6 wt control. The truncated isoform
band in contrast slightly thinner in the TrkB.TK+ mouse compared to the B6
wt control. Figure 3.34 B’ shows a significant decrease in truncated TrkB in the
TrkB.TK+mouse compared to the B6 wt control. Figure 3.34 B” shows a significant
increase in full length TrkB in the TrkB.TK+ mouse compared to the B6 wt control.
Descriptive statistics for fig. 3.34 are listed in table 3.29.
Table 3.29: Descriptive statistics for TrkB protein level in TrkB.T1+ and TrkB.TK+ mice com-
pared to B6 wt controls (fig. 3.34). he brain tissue was a complete brain homogenate.
Genotype TrkB isoform Mean±SEM
B6 wt FL normalized to 1
B6 wt T1 normalized to 1
TrkB.T1+ FL 1,698±0,2022
TrkB.T1+ T1 3,439±0,6720
TrkB.TK+ FL 5,470±1,011
TrkB.TK+ T1 0,5201±0,02452
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Figure 3.34: Quantification of TrkB (T1 and full length) in brain tissue of TrkB.T1+,
TrkB.TK+ and B6 wt control mice (A, B) Exemplified Western blots. The
antibodies used were anti-TrkB (rabbit, polyclonal, Milipore 07-225, 1:2000) and
anti-Tubulin (mouse monoclonal, Sigma-Aldrich, ® T9026, 1:10000). A’, A”, B’,
B” To B6 wt control mice normalized amount of TrkB (T1 and full length) in brain
tissue of TrkB.T1+ and TrkB.TK+ mice. Data presented as mean ± SEM. * = p
< 0.05, **= p < 0.01, student’s t-test.
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Neuroinflammation is thought to be one major risk factor from which the partheno-
genesis of various neurodegenerative diseases originates. The factors contributing
to the difficulties understanding neuroinflammation are diverse. One of the most
intriguing properties is the CNS’ inherent immune system. CNS has long been de-
scribed as being immune privileged with the BBB restricting access to the neuronal
structures and with the microglia, representing the CNS’ immune system. In order
to understand neuroinflammation the interaction of the different cell populations of
the CNS needs to be understood. The neurotrophic system has been studied for its
role in neuronal maintenance for the last decades. Neurotrophins, secreted growth
factors, signal through neurotrophin receptors and mediate neuronal survival, dif-
ferentiation, growth and are crucial for hippocampal learning mechanisms. The
past decade brought to attention that neurotrophins are not exclusively expressed
and acting in neurons and astrocytes, but in microglia and other cell populations
of the immune system (Meeker & Williams, 2014).
As a model for neuroinflammation, chronic CNS infection by Toxoplasma gondii
was chosen. After initial infection, this parasite takes up permanent residence
in the CNS to protect itself from the adaptive immune system of the host. The
transmission of T. gondii is facilitated by its ability to modify its host’s behavior.
A specific manipulation of the intermediate host’s behavior is typical for certain
parasites for their own selective benefit. Classic examples for this manipulation hy-
pothesis concern transmission through the food chain: an immature parasite resides
in an intermediate host, that must be eaten by a predatory definitive host before
the parasite can reach maturity and complete its sexual life cycle. By altering the
intermediate host’s behavior, the parasite increases the exposure of that very host
to the definite host. T. gondii provides a convincing example of such a manip-
ulatory parasite. Its definitive hosts are all members of the cat family (Felidae).
This is in accordance with the observation that T. gondii infected mice lose their
natural fear of the odor of cats and become instead attracted to cat urine (Berdoy
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et al., 2000). Additionally, it was shown that T. gondii infection affected learning
and memory in rats during Morris water maze experiments (Daniels et al., 2014).
In this work the effect of chronic murine neuroinflammation on the dendritic
architecture of B6 WT controls, the B6-p75NTR-/- mutant, and a more immunolog-
ically robust mouse strain to T. gondii infection (BALB/c), was investigated. As
the immune response in the CNS is mainly mediated by microglia, additional exper-
iments were aimed to gain, especially morphological, insights on the microglial re-
sponse on prolonged neuroinflammation. Furthermore, it was investigated whether
neurotrophin receptor levels were altered upon T. gondii infection.
4.1 Effects of p75NTR on dendritic architecture in
chronically T. gondii infected mice
A previous publication by Parlog et al. (2014) showed a significant loss in spine
density in cortical pyramidal neurons in chronically T. gondii infected B6 mice and
the decrease in dendritic complexity.
In accordance with these results, this work shows that in chronically T. gondii
infected B6 control mice hippocampal CA1 neurons are significantly less complex
compared to the untreated B6 control mice. The results also indicate that this
phenotype develops over time during the infection as 4w T. gondii infected B6
control mice show milder changes than the 8w T. gondii infected B6 mice (fig. 3.1).
Also, the dendritic spine density decreases upon T. gondii infection in cortical
and hippocampal pyramidal neurons in B6 control animals compared to untreated
controls. The data again indicates that the spine density decreases over time with
8w infected B6 control mice showing the lowest dendritic spine density and the
4w infected B6 control mice showing an intermediate phenotype between the B6
controls and the 8w T. gondii infected B6 mice (section 3.1.3).
In contrast to the B6 WT animals, the B6-p75NTR-/- mice show no significant
reduction in dendritic complexity on pyramidal CA1 neurons upon T. gondii infec-
tion (fig. 3.2) at all observed time point. However, a trend towards a decrease can
be observed without statistical significance. Intriguingly also the dendritic spine
density is not significantly altered 4w infected with T. gondii in the hippocampal
CA1 neurons and the basal tuft of cortical LV/VI pyramidal neurons. 8w into T.
gondii infection the dendritic decreased significantly in B6-p75NTR-/- mice, indicat-
ing that whatever mechanism slows the progression earlier during incubation is less
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effective at the later time point.
In a direct comparison between the B6 WT and B6-p75NTR-/- mice show that
similar to the results of Zagrebelsky et al. (2005) no significant difference in the
dendritic architecture of hippocampal CA1 neurons can be observed. Additionally,
the dendritic spine density is significantly increased in the basal tuft of CA1 neuron
in the B6-p75NTR-/- mice compared to the B6 controls as well on apical dendrites of
cortical LV/VI pyramidal neurons. Differences between these results and those of
the publication from Zagrebelsky et al. in 2005 could be explained by the methods:
The 2005 publication utilized mainly in vitro experiments and this work ex vivo
tissue.
The results indicate that some of the effects chronic toxoplasmosis has on den-
dritic architecture in the cortex, and the hippocampus could be mediated via the
p75NTR. Indeed, parasites have shown to mimic neurotrophic factors to prevent for
example caspase activation and thereby death of dopaminergic cells (Chuenkova and
Pereira, 2003). In their study, a neuraminidase/trans-sialidase has been identified
to mediate the observed effect, which they named parasite derived neurotrophic
factor (PDNF). Although not identified to this date it is possible that T. gondii
also secretes a protein which has a double function and effectively acts as a PDNF
to manipulate host behavior via p75NTR.
Another explanation derives from the concept that neurotrophin signaling op-
erates on a finely tuned scale of receptor distribution. Any imbalance can have a
great effect on neurons, e.g., imbalance of neurotrophin receptor isoforms TrkB.FL
and TrkB.T1 induces neuronal death (Vidaurre et al., 2012). Furthermore, it is
well established that p75NTR and TrkB act as counterparts in their modulation of
neuronal plasticity (Chao, 2003). Any receptor dysregulation by the parasite in-
cludes the potential to drastically influence neuronal maintenance. Neurotrophin
receptor levels are discussed below.
According to the motto form follows function these results indicate that by alter-
ing the form, the architecture of the neurons, their function could be changed too.
The neuronal arborization and the spine density are defining for the capability of
a neuron to participate in the communication. The dendritic spines represent the
post-synapse, and reduced overall spines therefor represent a reduced connectivity
for incoming signals of other neurons.
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4.2 B6 mice and BALB/c mice illustrate
substantially different progression of
toxoplasmosis - chronic vs latent
Silva et al. showed in 2010 that B6 mice are more sensitive to T. gondii infection
than BALB/c mice. The body weight of BALB/c mice indeed is not significantly
decreased 4 and 8 weeks after T. gondii infection (fig. 3.10). In contrast, B6 mice
(WT and p75NTR-/-) lose body weight significantly upon T. gondii infection. During
the experiments it was observed that the B6 mice showed reduced vitality: they did
not struggle or fight handling by the experimenter. On the contrary, the BALB/c
mice appeared more robust, tried to escape the experimenter and were more active
in their cages. Intriguingly also the effect of prolonged T. gondii infection on
neuronal architecture is less pronounced in BALB/c mice than in B6 mice. While
a trend for a decrease in dendritic spine density was observed in hippocampal CA1
pyramidal neurons and cortical LV/VI pyramidal neurons it was only found to be
significantly decreased in the basal tuft of CA1 neurons 8w post infection. This
is in strong contrast to what has been observed in the T. gondii infected B6 WT
mice, where the decrease is significant in both neuron types, basally and apically,
4w into the infection and even more pronounced 8w into the infection. As later
discussed also the microglial morphology upon T. gondii infection differs in these
mouse strains (section 4.3).
These results indicate that toxoplasmosis in BALB/c mice indeed represents the
latent state of the infection, in a way similar to that observed in immunocompetent
humans (Welter et al., 2007), while toxoplasmosis in B6 mice could be described as a
chronic state of the infection (confusingly these terms are both used in the literature
to describe the former, latent state), a situation in which the acute infection never
switches to the latent phase. In the case of B6 mice it maybe best compared to
human patients, which are immune deficient. In this patients, the parasite cannot
be controlled by the immune system. Most prominently in patients suffering from
the late stage of HIV infection (AIDS) or in patients receiving a donor organ, where
the immune system is supressed to prevent rejection (Robert-Gangneux & Dardé,
2012; Da Silva Meira et al., 2015; El Lakkis et al., 2015). This leads to dangerous,
in many cases life threatening encephalitis (Zhang et al., 2014).
Interestingly Welter et al. could show in 2007 that BALB/c mice, which were
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previously exposed toMyocoptes musculinus (small mites), became very sensitive to
T. gondii infection similar to the B6 phenotype. This suggests that some immuno-
logical priming could possibly weaken the resistance to the parasite. They show
that spleen cells had increased the levels of IL-4 in these double-infected mice. This
alteration was associated with severe encephalitis. Another
As a result of the strong immunological challenge to B6 mice, it was not possi-
ble to perform any behavioral or electrophysiological experiments. This has been
particularly underwhelming since the p75NTRExonIV-/- mutant crossbred with the
Thy1 -eGFP transgene is currently only available in B6 but not in BALB/c mice.
Correlating morphological findings in the B6-p75NTR-/- mutant with behavioral ex-
periments like the elevated plus maze or the Morris water maze are therefore cur-
rently not possible. Electrophysiological recordings, to estimate LTP and LTD for
example, were also impossible by the need to rest the animals for at least 24 h in
their final location before sacrificing and recording immediately after.
Another observation contributes to this issue: the virulence of the T. gondii
strain ME49 type II has increased without any indication of the cause. The infec-
tions for this thesis were achieved by injecting 2 tissue cysts intraperitoneally. In
consultation with Dr. Dunay on this issue, it was explained that when she started
working with this strain, she used to inject up to 10 cysts and reduced the number
over the years because of an inexplicable increase in virulence.
4.3 Microglial response to T. gondii infection
depends on mouse strain
It has been established that acute toxoplasmosis initiates microglial response and
activation (Chao, 1993; Schlüter 1995; Lüder, 1999, Fischer & Reichmann, 2001).
Immunological response in T. gondii infected mice is commonly analyzed and char-
acterized by FACS analysis to differentiate monocyte populations (Dunay & Sibley,
2010; Biswas et al., 2015).
The previously underserved morphological analysis of the Iba1+ cells in B6 and
BALB/c mice yields some intriguing results. In the B6 wild type and the BALB/c
wild type control mice the microglia show the morphological phenotype associated
with resting or surveillance in a CNS environment, which has not recently been
insulted or infected: a small cell body and long, wavy processes and low levels of
Iba1 immunoreactivity (Kettenmann et al., 2011).
87
4 Discussion
In contrast in T. gondii infected B6 and BALB/c mice Iba1+ cells alter their
morphological phenotype substantially. In B6 mice (WT and p75NTR-/-) the Iba1
staining depicts cells which do not resemble typical textbook microglia, activated
or resting. The overlay of the Iba1 staining and the Thy1 -eGFP shows that the
microglia are wrapping the neurons in the T. gondii infected B6 mice. They extend
to cover the cell soma of CA1 neurons and the primary apical dendrite. This
association of Iba1+ cells with neuronal structures is so apparent that it can be
perceived without the GFP overlay. Additionally, the Iba1 associates with what
seems to be blood vessels. Microglial wrapping of neuronal cell bodies is also part of
the phenotype observed after peripheral nerve axotomy (Moran & Greaber, 2004).
This phenomenon has also been reported in hippocampal organotypic cultures after
an ischemic insult and in the cerebral cortex during either acute focal inflammation
(Trapp et al., 2007) or following LPS injection (Chen et al., 2012). Microglial
wrapping (and synaptic stripping) is usually considered to be a neuroprotective
process (Kreutzberg, 1996). Whether this wrapping is always neuroprotective is
still not completely understood and discussed controversially (Yamada et al., 2011;
Chen et al., 2014).
Iba1+ cells in BALB/c mice also alter their morphology upon T. gondii infection.
In contrast to the B6 mice, manually counting Iba1+ cells is reliably precise in T.
gondii infected BALB/c mice with DAPI co-staining. These cells resemble what
has been described as activated microglia in the literature. The enlarged cell soma
is typical. Also, the processes are less wavy and shorter and can best be described as
being spiky. Also, no association with blood vessel was observed during experiments
and analysis.
The Iba1 immunoreactivity increases manifold in B6 and BALB/c mice upon T.
gondii infection compared to the controls, which is another indicator of microglial
activation.
Although Silva et al. described in 2010 that B6 mice are more sensitive to T.
gondii infection than BALB/c mice it has, to my best knowledge, never been shown
that the microglia in these mice strains react completely different morphologically
to the very same parasite infection, in their association with neurons and blood
vessels. This raises the question whether it is valid to transfer microglial findings in
mice, where they obviously depend on the genetic background, to any other species
T. gondii can infect, including humans.
The analysis to estimate the concentration of Iba1+ cells in T. gondii infected B6
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mice (WT and p75NTR-/-)is not very precise, as the cells overlap and lose their indi-
vidual shape. The DAPI co-staining, which makes manual counting in not-infected
control mice reliably precise, is not sufficient to separate Iba1+ cells dependable in
T. gondii infected B6 mice. Therefore the values estimated for Iba1+ cell concen-
tration in T. gondii infected B6 mice could yield some inaccuracy and bias from
manual counting. With the applied method of analysis, the Iba1+ cells in T. gondii
infected B6 WT, and B6-p75NTR-/- can not be distinguished. It is nevertheless likely
that the microglial concentration increases significantly in B6 and BALB/c mice
upon T. gondii infection.
The results indicate that the effect of T. gondii infection on microglia activation
is not mediated primarily by p75NTR and that microglia in B6 and BALB/c mice
react differently to the parasite. It has been shown before that the severity of T.
gondii induced encephalitis in B6 mice is associated with increased VCAM-1 and
ALCAM expression in the CNS and higher BBB permeability (Silva et al., 2010).
In contrast to FACS analysis, which utilizes a variety of different markers to
differentiate between monocyte populations, the morphological analysis of Iba1+
cells lacks a precise distinction. A co-staining with a anti-F4/80 antibody revealed
the same finding as for the Iba1 staining. This means that the observed morphology
in T. gondii infected mice is not derived of a cross-reaction with the anti-Iba1
antibody. F4/80 is another microglia marker. A differentiation between CNS native
microglia and invading macrophages is not possible with Iba1 or F4/80.
4.4 Microglial concentration in B6-p75NTRExonIV-/-
mice is increased compared to the wild type
Additionally to the effect of T. gondii infection on microglial concentration in B6
and BALB/c mice the microglial concentration in B6-p75NTR-/- controls was com-
pared to B6 WT controls. Although not reaching the levels of T. gondii infected
mice B6-p75NTR-/- control have significantly higher microglia concentration com-
pared to the B6WT control. Also, the higher immunoreactivity of Iba1 is significant
compared to the B6 WT control (and the BALB/c). To the author’s knowledge,
microglial density in p75NTR-/- has never been analyzed. The p75NTR is expressed
on microglia and macrophages (Nakajima et al., 1998, 2001; Dowling et al., 1999).
A mechanism or signaling pathway which indicates the lack of p75NTR increases
microglial proliferation is yet to be found. It is known that microglia promote
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learning-dependent synapse formation through BDNF mediated synaptic pruning
(Parkhurst et al., 2013), whether p75NTR plays a role in this context is also unclear.
4.5 Decreased neurotrophin receptor protein levels
in T. gondii infected mice
To gain further insight into the participation of neurotrophin signaling in T. gondii
elicited neuroinflammation the amount of TrkB and p75NTR was measured using
Western blot. Both neurotrophin receptors work in tandem and are thought to
work in opposing manner. Both the receptors also form heterodimers, which alters
their affinity to BDNF and NT-4.
B6 and BALB/c mice both show reduced p75NTR protein levels upon T. gondii
infection in the cortex and both TrkB isoforms are also significantly reduced in the
cortex, also in the B6-p75NTR-/- mutant. In the hippocampus, the amount of full-
length TrkB is not significantly altered upon infection, but the T. gondii infected
B6 WT mice show a decrease in trend. Solely in the T. gondii infected B6 WT
mice the truncated TrkB isoform is significantly decreased upon T. gondii infection.
The B6-p75NTR-/- is not affected, as well as the BALB/c strain. Interestingly the
amount of full-length TrkB is higher in the cortex of B6-p75NTR-/- control mice
compared to their B6 WT counterparts.
BDNF and NT-4, the neurotrophins activating TrkB, are predominantly ex-
pressed in the dentate gyrus and the CA3 region of the hippocampus but also
less profound throughout the whole CNS (Conner et al., 1997). A reduction in
TrkB could possibly indicate reduced BNDF signaling. BDNF signaling is crucial
for the maintenance of the neuronal network as it supports the survival of existing
neurons and encourages the growth and differentiation of new neurons and synaptic
connections. It has been shown that it is crucial for forming memories in the hip-
pocampus (Korte et al., 1995). On the other side of the scale, BNDF also activates
p75NTR, which is thought to counteract the BDNF-TrkB signaling. By also reduc-
ing T. gondii might be manipulatively numbing the host’s neurotrophic system by
down-regulating its receptors.
In preparation for future experiments, two additional B6 mutants were analyzed
for their TrkB levels. The B6-TrkB.T1 mutant shows significantly higher TrkB.T1
when compared to the B6 WT while the full-length isoform is not altered. The
B6-TrkB.TK+ mutant shows significantly less amount of TrkB.T1 when compared
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to the B6 WT while the full-length isoform levels are significantly higher. These
results confirm that the mutants overexpress one isoform each.
The third TrkB isoform, the T2, as well as TrkA and TrkC, were not analyzed
in this work.
4.6 Inconsistencies in p75NTR literature
One issue, which needs to be addressed, is that existing knowledge about the p75NTR
is mainly derived from two different genetic mutants. Lee et al. showed in 1992
that a targeted mutation in the exon III of the p75NTR gene leads to deficits in the
peripheral sensory nervous system (the p75NTR gene contains six exons in total).
Since then different groups used this model to study p75NTR knock out in their
research focus. Nearly a decade later von Schack et al. (2001) identified an isoform
of the p75NTR protein that derived from alternate splicing of the exon III in the
p75NTR gene locus. This isoform is also functionally intact in the mutant mouse
line lacking the exon III by Lee et al. For this reason, von Schack et al. generated
another mutant line, lacking the exon IV. The publication shows that mice with
p75NTR-ExonIV-/- present drastic nervous system defects. In contrast to the mutant
lacking the exon III it also reveals a previously unknown role of p75NTR in the
formation of blood vessels. Von Schack et al. show that the mutant lacking the
exon III transcripts into the short s-p75NTR transcript, which differs from the full-
length p75NTR (FL-p75NTR) protein. In contrast to the FL-p75NTR, the s-p75NTR
lacks three of the four cysteine-rich domains. They furthermore show that the
s-p75NTR is coexpressed with the FL-p75NTR in human, rat, and mouse thereby
seemingly highly conserved across the species. The p75NTR exonIV lacking mutant
in contrast to the 75NTR exonIII lacking mutant lacks a discrete 62KDa protein in
Schwann cells. The lack of both p75NTR proteins leads to a severe phenotype, e.g.,
partial perinatal lethality and additional defects in the vascular system that have
not been observed in the exonIII lacking p75NTR mutants.
Despite these insights the p75NTR-ExonIII null mutant continuous to be used in
the field (Bui et al., 2002; Barrett et al., 2010). Its s-p75NTR isoform is seldom
discussed in the publications (Greferath et al., 2000). Following that also review
papers referring to this publication fail to explain the problematic nature of this
mutant line. The p75NTR-ExonIII null mouse is simply called a null or p75NTR knock
out mouse (Greferath et al., 2000; Barrett et al., 2010). Also, the p75NTR-ExonIV
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null mutant is not undisputed. In 2004 Paul et al. published that a pro-apoptotic
fragment of the p75NTR is expressed in this mutant mouse line. In accordance
with von Schack et al. they show a lack of the 62 kDa transcript but an additional
26 kDa transcript, which is absent in the p75NTR-ExonIII-/- mutant. This fragment of
the p75NTR protein contains a portion of the ECD (extracellular domain) and the
transmembrane and intracellular domains. Overexpression of this 26KDa protein
fragment in heterologous cells, in the 2004 study, resulted in an activation of Jun
kinase and also induces pro-caspase-3 cleavage. This indicates that the fragment
activates p75NTR signaling cascades in the p75NTR-ExonIV-/- mutant. Paul et al.
conclude that the p75NTR-ExonIV-/- phenotype as seen by von Schack et al. in 2001
could reflect a gain-of-function mutation rather than loss of p75NTR function. In
2011 Bogenmann et al. introduced a mutant line with floxed exons IV-VI. It has
been studied, for example, by Baeza-Raja et al. in 2016 and directly been compared
to the exon III null mutant, described as p75NTRKO in their publication, again
without discussing ramifications.
This further questions existing understanding of the p75NTR. Its complex sig-
naling pathways and multiple interaction partners are already complicating the
research. Studies have for example shown that neuron type specific signaling by
the p75NTR death receptor is regulated by differential proteolytic cleavage (Vicario
et al., 2015). This work utilized the p75NTR-ExonIV null mutant without reassessing
the 26KDa fragment described by Paul et al. in 2004. Optimally another mutant
mouse line would be generated, lacking the complete p75NTR gene. A floxed p75NTR
would open up even more possibilities to study the impact of p75NTR during devel-
opment and in mature mice. Consequently, some crucial experiments and results,
which emerged in the last 25 years, need to be repeated and compared between
established mutant mouse lines.
4.7 Conclusions and outlook
On the one hand, the results indicate that T. gondii infection in B6 mice does
not reflect the latent phase of toxoplasmosis but a chronic inflammation caused
by the parasite, similarly observed in immune deficient humans. Consequently,
the results are not adequate to explain any of the subtle behavior changes upon
T. gondii infection observed in mouse strains which develop latent toxoplasmosis.
The contribution of p75NTR to the T. gondii inflicted regression of neuronal struc-
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tures is therefore possibly less specific to the parasite manipulating the host than
to prolonged CNS inflammation or even encephalitis. The results indicate that
in B6-(p75NTRExonIV-/-) mice the decrease in dendritic spine density and dendritic
complexity of excitatory pyramidal neurons in the hippocampus and the cortex
is slowed in its progression compared to the B6 WT control. This is especially
noticeably 4w into the T. gondii infection. However, 8w into the infection the
spine density is effectively as much decreased in the mutant as in the B6 WT mice.
Solely the dendritic complexity proves to be more robust 8w into the infection in
the mutant. Shortly after the B6 mice succumb to the infection. Intriguingly the
hippocampal amount of TrkB is significantly reduced in the B6 WT mice and not
significantly altered in the B6-p75NTRExonIV-/- upon the infection. This shows that
to some extend the degenerative effect of T. gondii infection in B6 mice could be
mediated or amplified by p75NTR and TrkB signaling, both of which are activated
by BDNF.
On the other hand T. gondii infection in BALB/c mice could constitute latent
toxoplasmosis, as described in immune competent humans. While in accordance
with the generally stronger resistance to T. gondii also the neurons are less affected
by its infection. Nevertheless, the total amount of p75NTR and TrkB is reduced in
the cortex, indicating a possible manipulation of the parasite within the CNS via
the neurotrophic system.
While the microglia (Iba1+ cells) were clearly activated upon T. gondii infection
in the B6 (mutant and WT) and the BALB/c mice, conclusive statements about
differences in the total number of Iba1+ cells are unreasonable at this point with
the aforementioned uncertainties in the distinction of single cells in the B6 mice
because of the extensive morphological changes. It is still noteworthy to point out
the vivid difference in microglial morphology upon T. gondii infection between the
B6 and the BALB/c mice. A connection between microglial response to the parasite
and resistance to its effects on the host is yet unclear.
The amount of Iba1+ cells is significantly higher in the B6-p75NTRExonIV-/- mutant
than in the B6 controls. While p75NTR is normally expressed on microglia, it is not
clear how it could affect proliferation.
As for the outlook, the results have shown that in B6 as well as in BALB/c
mice TrkB protein levels are reduced upon T. gondii infection. There are two B6
mutant mouse lines available, each overexpressing one of the two TrkB isoforms.
Analyzing these would currently be the easiest and fastest way to generate more
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data on neurotrophin receptor involvement in T. gondii inflicted neuroinflamma-
tion. From a methodological viewpoint, it could be beneficial to refrain from the
Western blot and instead perform qPCR and ELISA experiments for a better com-
parability between the different categories and a higher data throughput with a
simpler workflow.
To gain a more comprehensive understanding of p75NTR involvement in CNS
immunity, a conditional full knockout mutant should be generated and bred into
the different mouse strains. Firstly to disentangle the results from any translated
p75NTR fragments which are present in the p75NTRExonIII-/- mutant and could be
present in the p75NTRExonIV-/-, secondly to differentiate the results, depending on
the cell type expressing or lacking the receptor. Optimally some of the most cru-
cial insights into p75NTR signaling, which were generated by the present mutant
lines, would be experimentally verified. Conflicting results could possibly indicate
signaling roles by the aforementioned protein fragments.
While the B6 mouse strain is not suitable to study latent toxoplasmosis, it could
be used to examine chronic neuroinflammation with an active pathogen in contrast
to the more in vitro like approach with LPS treatments mimicking CNS infections or
insults. Additionally, microglial neuron wrapping could be studied with this model
to gain further insights into the pending question whether it is neuroprotective or
neurotoxic by infecting B6 mice with the wide array of available transgenes for this
strain.
The BALB/c mouse strain, however, reflects the latent toxoplasmosis and could
be used to study the more subtle CNS changes promoted by the parasite to alter
the behavior. It is, therefore, necessary to breed the genetic tools (Thy1 -eGFP,
neurotrophin receptor mutants) into the BALB/c background. That would open
up the possibility to correlate behavioral and electrophysiological data to the mor-
phological results of neurons and microglia reaction to T. gondii infection presented
in this work.
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